Apparatus and methods for treating an intervertebral disc by ablation of disc tissue. A method of the invention includes positioning at least one active electrode within the intervertebral disc, and applying at least a first high frequency voltage between the active electrode(s) and one or more return electrode(s), wherein the volume of the nucleus pulposus is decreased, pressure exerted by the nucleus pulposus on the annulus fibrosus is reduced, and discogenic pain of a patient is alleviated. In other embodiments, a curved or steerable probe is guided to a specific target site within a disc to be treated, and the disc tissue at the target site is ablated by application of at least a first high frequency voltage between the active electrode(s) and one or more return electrode(s). A method of making an electrosurgical probe is also disclosed.
|
1. A method of treating an inter-vertebral disc, comprising:
a) contacting at least a first region of a nucleus pulposus of the inter-vertebral disc with at least one active electrode of an electrosurgical system, the at least one active electrode disposed on a shaft of an electrosurgical probe, and the at least one active electrode functionally coupled to a power supply unit; and
b) applying a first high frequency voltage between the at least one active electrode and at least one return electrode, wherein at least a portion of the nucleus pulposus is ablated and the volume of the nucleus pulposus is decreased .
33. A method of treating an inter-vertebral disc, comprising:
providing an electrosurgical system including a probe and a power supply unit, wherein the probe includes a shaft and a handle, the shaft including a distal end portion, at least one active electrode, and at least one return electrode, the at least one active electrode located on the distal end portion of the shaft, the distal end portion of the shaft having a pre-defined bias in the longitudinal direction thereof;
inserting the distal end portion of the shaft within the disc; and
ablating at least a portion of nucleus pulposus tissue from the disc, wherein at least one channel is formed within the nucleus pulposus tissue.
43. A method of treating an inter-vertebral disc with an electrosurgical system, the electrosurgical system including a probe having a shaft, the shaft including a shaft distal end portion, an active electrode disposed on the shaft distal end portion, and a return electrode disposed proximal to the active electrode, the method comprising:
a) contacting a nucleus pulposus of the disc with the active electrode;
b) applying a high frequency voltage between the active electrode and the return electrode, wherein the high frequency voltage is sufficient to ablate disc tissue; and
c) during the applying step, translating the shaft distal end portion within the nucleus pulposus, wherein tissue of the nucleus pulposus is ablated and the volume of the nucleus pulposus is decreased.
2. The method of
c) contacting at least a second region of the nucleus pulposus of the inter-vertebral disc with the at least one active electrode, and thereafter, repeating said step b).
3. The method of
4. The method of
5. The method of
d) positioning the at least one active electrode adjacent to the channel wall; and
e) coagulating tissue of the nucleus pulposus by applying a second high frequency voltage between the at least one active electrode and the at least one return electrode.
6. The method of
7. The method of
8. The method of
9. The method of
10. The method of
f) prior to said step b), providing an electrically conductive fluid at the at least a first region of the nucleus pulposus.
11. The method of
12. The method of
13. The method of
15. The method of
16. The method of
17. The method of
18. The method of
19. The method of
20. The method of
21. The method of
22. The method of
23. The method of
24. The method of
25. The method of
26. The method of
27. The method of
28. The method of
29. The method of
30. The method of
31. The method of
32. The method of
34. The method of
35. The method of
36. The method of
37. The method of
removing the shaft from the disc, wherein said removing step causes the low molecular weight gaseous materials to be exhausted from the disc.
38. The method of
39. The method of
after said ablating step, applying a second high frequency voltage between the at least one active electrode and the at least one return electrode, wherein the second high frequency voltage is sufficient to coagulate disc tissue adjacent to the distal end portion of the shaft.
40. The method of
before said ablating step, contacting the at least one active electrode with a quantity of an electrically conductive fluid.
41. The method of
42. The method of
44. The method of
45. The method of
46. The method of
47. The method of
48. The method of
49. The method of
50. The method of
d) inserting an ancillary introducer needle into the disc; and
e) advancing, via the ancillary introducer needle, an ancillary device into the nucleus pulposus, wherein the ancillary device comprises an endoscope, an optical fiber, an aspiration device, a fluid delivery assembly, or a return electrode.
51. The method of
52. The method of
53. The method of
f) advancing the shaft distally through the nucleus pulposus until the shaft distal end portion contacts an inner wall of an annulus fibrosus; and thereafter, retracting the shaft a defined distance.
54. The method of
g) determining a depth of penetration of the shaft distal end portion within the disc.
55. The method of
56. The method of
h) advancing the shaft distal end portion through the nucleus pulposus until the shaft distal end portion contacts the annulus fibrosus; and thereafter,
i) retracting the shaft distal end portion a defined distance.
57. The method of
h) advancing the shaft distal end portion through the nucleus pulposus until the mechanical stop contacts a proximal end of the introducer needle.
0. 58. The method of
|
|||||||||||||||||||||||||||
The present invention This application is a REISSUE application of U.S. patent application Ser. No. 09/676,194, filed Sep. 28, 2000. U.S. patent application Ser. No. 09/676,194, filed Sep. 28, 2000, now U.S. Pat. No. 6,602,248 claims priority from U.S. Provisional Application No. 60/224,107, filed Aug. 9, 2000, and from PCT and is also a continuation-in-part application of International Application No. PCT/US00/13706, filed May 17, 2000, and which claims priority from U.S. patent application Ser. No. 09/316,472, filed May 21, 1999, now U.S. Pat. No. 6,624,650, which is a continuation-in-part of U.S. patent application Ser. No. 09/295,687, filed Apr. 21, 1999, now U.S. Pat. No. 6,203,542, and U.S. patent application Ser. Nos. 09/054,323, now U.S. Pat. No. 6,063,079, and 09/268,616, now U.S. Pat. No. 6,159,208, filed Apr. 2, 1998 and Mar. 15, 1999, respectively, each of which are continuation-in-parts of U.S. patent application Ser. No. 08/990,374, filed Dec. 15, 1997, now U.S. Pat. No. 6,109,268, which is a continuation-in-part of U.S. patent application Ser. No. 08/485,219, filed on Jun. 7, 1995, now U.S. Pat. No. 5,697,281, the complete disclosures of which are incorporated herein by reference for all purposes. This application U.S. patent application Ser. No. 09/676,194, filed Sep. 28, 2000, is also a continuation-in-part of U.S. patent application Ser. No. 09/026,851, filed Feb. 20, 1999, now U.S. Pat. No. 6,277,112, which is a continuation-in-part of U.S. patent application Ser. No. 08/690,159, filed Jul. 18, 1996, now U.S. Pat. No. 5,902,272, the complete disclosure of which is incorporated herein by reference for all purposes.
The present invention is related to commonly assigned U.S. patent application Ser. No. 09/181,926, filed Oct. 28, 1998, U.S. patent application Ser. No. 09/130,804, filed Aug. 7, 1998, now U.S. Pat. No. 6,045,532, U.S. patent application Ser. No. 09/058,571, filed on Apr. 10, 1998, now U.S. Pat. No. 6,142,992, U.S. patent application Ser. No. 09/248,763, filed Feb. 12, 1999, now U.S. Pat. No. 6,149,620, U.S. patent application Ser. No. 09/026,698, filed Feb. 20, 1998, now U.S. Pat. No. 6,620,155, U.S. patent application Ser. No. 09/074,020, filed on May 6, 1998, now U.S. Pat. No. 6,363,937, U.S. patent application Ser. No. 09/010,382, filed Jan. 21, 1998, now U.S. Pat. No. 6,190,381, U.S. patent application Ser. No. 09/032,375, filed Feb. 27, 1998, now U.S. Pat. No. 6,355,032, U.S. patent application Ser. Nos. 08/977,845, filed on Nov. 25, 1997, now U.S. Pat. No. 6,210,402; 08/942,580, filed on Oct. 2, 1997, now U.S. Pat. No. 6,159,194, U.S. patent application Ser. No. 08/753,227, filed on Nov. 22, 1996, now U.S. Pat. No. 5,873,855, U.S. patent application Ser. No. 08/687,792, filed on Jul. 18, 1996, now U.S. Pat. No. 5,843,019, and PCT International Application, U.S. National Phase Ser. No. PCT/US94/05168 filed on May 10, 1994, now U.S. Pat. No. 5,697,909, which was a continuation-in-part of U.S. patent application Ser. No. 08/059,681, filed on May 10, 1993, now abandoned, which was a continuation-in-part of U.S. patent application Ser. No. 07/958,977, filed on Oct. 9, 1992 now U.S. Pat. No. 5,366,443, which was a continuation-in-part of U.S. patent application Ser. No. 07/817,575, filed on Jan. 7, 1992, now abandoned, the complete disclosures of which are incorporated herein by reference for all purposes. The present invention is also related to commonly assigned U.S. Pat. No. 5,697,882, filed Nov. 22, 1995, the complete disclosure of which is incorporated herein by reference for all purposes.
The present invention relates to a medical apparatus having a distal curved configuration which avoids contact of the apparatus distal end with an introducer device. The present invention also relates to the field of electrosurgery, and more particularly to surgical devices and methods which employ high frequency electrical energy to treat tissue in regions of the spine. The present invention is particularly suited for the treatment of the discs, cartilage, ligaments, and other tissue within the vertebral column.
The major causes of persistent, often disabling, back pain are disruption of the disc annulus, chronic inflammation of the disc, contained and non-contained herniation, and relative instability of the vertebral bodies surrounding a given disc, such as the instability that often occurs due to a stretching of the interspinous tissue surrounding the vertebrae. Intervertebral discs mainly function to cushion and tether the vertebrae, while the interspinous tissue (i.e., tendons and cartilage, and the like) function to support the vertebrae so as to provide flexibility and stability to the patient's spine.
Spinal discs comprise a central hydrophilic cushion, the nucleus pulposus, surrounded by a multi-layered fibrous ligament, the annulus fibrous. As discs degenerate, they lose their water content and height, bringing the adjoining vertebrae closer together. This results in a weakening of the shock absorption properties of the disc and a narrowing of the nerve openings in the sides of the spine which may pinch these nerves. This disc degeneration can eventually cause back and leg pain. Weakness in the annulus from degenerative discs or disc injury can allow fragments of nucleus pulposus from within the disc space to migrate through the annulus fibrosus and into the spinal canal. There, displaced nucleus pulposus tissue, or protrusion of the annulus fibrous, e.g., due to herniation, may impinge on spinal nerves or nerve roots. A weakening of the annulus fibrosus can cause the disc to bulge, e.g., a contained herniation, and the mere proximity of the nucleus pulposus or the damaged annulus to a nerve can cause direct pressure against the nerve, resulting in pain and sensory and motor deficit.
Often, inflammation from disc herniation can be treated successfully by non-surgical means, such as rest, therapeutic exercise, oral anti-inflammatory medications or epidural injection of corticosteriods. Such treatments result in a gradual but progressive improvement in symptoms and allow the patient to avoid surgical intervention.
In some cases, the disc tissue is irreparably damaged, thereby necessitating removal of a portion of the disc or the entire disc to eliminate the source of inflammation and pressure. In more severe cases, the adjacent vertebral bodies must be stabilized following excision of the disc material to avoid recurrence of the disabling back pain. One approach to stabilizing the vertebrae, termed spinal fusion, is to insert an interbody graft or implant into the space vacated by the degenerative disc. In this procedure, a small amount of bone may be grafted and packed into the implants. This allows the bone to grow through and around the implant, fusing the vertebral bodies and preventing reoccurrence of the symptoms.
Until recently, surgical spinal procedures resulted in major operations and traumatic dissection of muscle and bone removal or bone fusion. To overcome the disadvantages of traditional traumatic spine surgery, minimally invasive spine surgery was developed. In endoscopic spinal procedures, the spinal canal is not violated and therefore epidural bleeding with ensuing scarring is minimized or completely avoided. In addition, the risk of instability from ligament and bone removal is generally lower in endoscopic procedures than with open procedures. Further, more rapid rehabilitation facilitates faster recovery and return to work.
Minimally invasive techniques for the treatment of spinal diseases or disorders include chemonucleolysis, laser techniques, and mechanical techniques. These procedures generally require the surgeon to form a passage or operating corridor from the external surface of the patient to the spinal disc(s) for passage of surgical instruments, implants and the like. Typically, the formation of this operating corridor requires the removal of soft tissue, muscle or other types of tissue depending on the procedure (i.e., laparascopic, thoracoscopic, arthoroscopic, back, etc.). This tissue is usually removed with mechanical instruments, such as pituitary rongeurs, curettes, graspers, cutters, drills, microdebriders and the like. Unfortunately, these mechanical instruments greatly lengthen and increase the complexity of the procedure. In addition, these instruments might sever blood vessels within this tissue, usually causing profuse bleeding that obstructs the surgeon's view of the target site.
Once the operating corridor is established, the nerve root is retracted and a portion or all of the disc is removed with mechanical instruments, such as a pituitary rongeur. In addition to the above problems with mechanical instruments, there are serious concerns because these instruments are not precise, and it is often difficult, during the procedure, to differentiate between the target disc tissue, and other structures within the spine, such as bone, cartilage, ligaments, nerves and non-target tissue. Thus, the surgeon must be extremely careful to minimize damage to the cartilage and bone within the spine, and to avoid damaging nerves, such as the spinal nerves and the dura mater surrounding the spinal cord.
Lasers were initially considered ideal for spine surgery because lasers ablate or vaporize tissue with heat, which also acts to cauterize and seal the small blood vessels in the tissue. Unfortunately, lasers are both expensive and somewhat tedious to use in these procedures. Another disadvantage with lasers is the difficulty in judging the depth of tissue ablation. Since the surgeon generally points and shoots the laser without contacting the tissue, he or she does not receive any tactile feedback to judge how deeply the laser is cutting. Because healthy tissue, bones, ligaments and spinal nerves often lie within close proximity of the spinal disc, it is essential to maintain a minimum depth of tissue damage, which cannot always be ensured with a laser.
Monopolar and bipolar radiofrequency devices have been used in limited roles in spine surgery, such as to cauterize severed vessels to improve visualization. Monopolar devices, however, suffer from the disadvantage that the electric current will flow through undefined paths in the patient's body, thereby increasing the risk of undesirable electrical stimulation to portions of the patient's body. In addition, since the defined path through the patient's body has a relatively high impedance (because of the large distance or resistivity of the patient's body), large voltage differences must typically be applied between the return and active electrodes in order to generate a current suitable for ablation or cutting of the target tissue. This current, however, may inadvertently flow along body paths having less impedance than the defined electrical path, which will substantially increase the current flowing through these paths, possibly causing damage to or destroying surrounding tissue or neighboring peripheral nerves.
Other disadvantages of conventional RF devices, particularly monopolar devices, is nerve stimulation and interference with nerve monitoring equipment in the operating room. In addition, these devices typically operate by creating a voltage difference between the active electrode and the target tissue, causing an electrical arc to form across the physical gap between the electrode and tissue. At the point of contact of the electric arcs with tissue, rapid tissue heating occurs due to high current density between the electrode and tissue. This high current density causes cellular fluids to rapidly vaporize into steam, thereby producing a “cutting effect” along the pathway of localized tissue heating. Thus, the tissue is parted along the pathway of evaporated cellular fluid, inducing undesirable collateral tissue damage in regions surrounding the target tissue site. This collateral tissue damage often causes indiscriminate destruction of tissue, resulting in the loss of the proper function of the tissue. In addition, the device does not remove any tissue directly, but rather depends on destroying a zone of tissue and allowing the body to eventually remove the destroyed tissue.
Many patients experience discogenic pain due to defects or disorders of intervertebral discs. Such disc defects include annular fissures, fragmentation of the nucleus pulposus, and contained herniation. A common cause of pain related to various disc disorders is compression of a nerve root by the disc. In many patients for whom major spinal surgery is not indicated, discogenic pain naturally diminishes in severity over an extended period of time, perhaps several months. There is a need for a minimally invasive method to treat such patients in order to alleviate the chronic, and often debilitating, pain associated with spinal nerve root compression. The instant invention provides methods for decompressing nerve roots by ablation of disc tissue at relatively low temperatures during a percutaneous procedure, wherein the volume of the disc is decreased and discogenic pain is alleviated.
The present invention provides systems, apparatus, and methods for selectively applying electrical energy to structures within a patient's body, such as the intervertebral disc. The systems and methods of the present invention are useful for shrinkage, ablation, resection, aspiration, and/or hemostasis of tissue and other body structures in open and endoscopic spine surgery. In particular, the present invention includes a method and system for debulking, ablating, and shrinking the disc.
The present invention further relates to an electrosurgical probe including an elongated shaft having first and second curves in the distal end portion of the shaft, wherein the shaft can be rotated within an intervertebral disc to contact fresh tissue of the nucleus pulposus. The present invention also relates to an electrosurgical probe including an elongated shaft, wherein the shaft distal end can be guided to a specific target site within a disc, and the shaft distal end is adapted for localized ablation of targeted disc tissue. The present invention further relates to a probe having an elongated shaft, wherein the shaft includes an active electrode, an insulating collar, and an outer shield, and wherein the active electrode includes a head having an apical spike and a cusp. The present invention still further relates to a method for ablating disc tissue with an electrosurgical probe, wherein the probe includes an elongated shaft, and the shaft distal end is guided to a specific target site within a disc.
In one aspect, the present invention provides a method of treating a herniated intervertebral disc. The method comprises positioning at least one active electrode within the intervertebral disc. High frequency voltage is applied between the active electrode(s) and one or more return electrode(s) to debulk, ablate, coagulate and/or shrink at least a portion of the nucleus pulposus and/or annulus. The high frequency voltage effects a controlled depth of thermal heating to reduce the water content of the nucleus pulposus, thereby debulking the nucleus pulposus and reducing the internal pressure on the annulus fibrosis.
In an exemplary embodiment, an electrically conductive media, such as isotonic saline or an electrically conductive gel, is delivered to the target site within the intervertebral disc prior to delivery of the high frequency energy. The conductive media will typically fill the entire target region such that the active electrode(s) are submerged throughout the procedure. In other embodiments, the extracellular conductive fluid (e.g., the nucleus pulposus) in the patient's disc may be used as a substitute for, or as a supplement to, the electrically conductive media that is applied or delivered to the target site. For example, in some embodiments, an initial amount of conductive media is provided to initiate the requisite conditions for ablation. After initiation, the conductive fluid already present in the patient's tissue is used to sustain these conditions.
In another aspect, the present invention provides a method of treating a disc having a contained herniation or fissure. The method comprises introducing an electrosurgical instrument into the patient's intervertebral disc either percutaneously or through an open procedure. The instrument is steered or otherwise guided into close proximity to the contained herniation or fissure and a high frequency voltage is applied between an active electrode and a return electrode so as to debulk the nucleus pulposus adjacent the contained herniation or fissure. In some embodiments a conductive fluid is delivered into the intervertebral disc prior to applying the high frequency voltage to ensure that sufficient conductive fluid exists for plasma formation and to conduct electric current between the active and return electrodes. Alternatively, the conductive fluid can be delivered to the target site during the procedure. The heating delivered through the electrically conductive fluid debulks the nucleus pulposus, and reduces the pressure on the annulus fibrosus so as to reduce the pressure on the affected nerve root and alleviate neck and back pain.
In another aspect, the present invention provides a method for treating degenerative intervertebral discs. The active electrode(s) are advanced into the target disc tissue in an ablation mode, where the high frequency voltage is sufficient to ablate or remove the nucleus pulposus through molecular dissociation or disintegration processes. In these embodiments, the high frequency voltage applied to the active electrode(s) is sufficient to vaporize and electrically conductive fluid (e.g., gel, saline and/or intracellular fluid) between the active electrode(s) and the tissue. Within the vaporized fluid, an ionized plasma is formed and charged particles (e.g., electrons) cause the molecular breakdown or disintegration of several cell layers of the nucleus pulposus. This molecular dissociation is accompanied by the volumetric removal of the tissue. This process can be precisely controlled to effect the volumetric removal of tissue as thin as 10 microns to 150 microns with minimal heating of, or damage to, surrounding or underlying tissue structures. A more complete description of this phenomenon is described in commonly assigned U.S. Pat. No. 5,697,882 the complete disclosure of which is incorporated herein by reference.
An apparatus according to the present invention generally includes a shaft having proximal and distal end portions, an active electrode at the distal end and one or more connectors for coupling the active electrode to a source of high frequency electrical energy. The probe or catheter may assume a wide variety of configurations, with the primary purpose being to introduce the electrode assembly into the patient's disc (in an open or endoscopic procedure) and to permit the treating physician to manipulate the electrode assembly from a proximal end of the shaft. The probe shaft can be flexible, curved, or steerable so as to allow the treating physician to move the active electrode into close proximity of the region of the disc, e.g., herniation, to be treated. The electrode assembly includes one or more active electrode(s) and a return electrode spaced from the active electrode(s) either on the instrument shaft or separate from the instrument shaft.
The active electrode(s) may comprise a single active electrode, or an electrode array, extending from an electrically insulating support member, typically made of an inorganic material such as ceramic, silicone or glass. The active electrode will usually have a smaller exposed surface area than the return electrode, such that the current densities are much higher at the active electrode than at the return electrode. Preferably, the return electrode has a relatively large, smooth surface extending around the instrument shaft to reduce current densities, thereby minimizing damage to adjacent tissue.
In another aspect, the present invention provides a method of treating an intervertebral disc, the method comprising contacting at least a first region of the intervertebral disc with at least one active electrode of an electrosurgical system. The at least one active electrode may be disposed on the distal end portion of a shaft of the electrosurgical system. A first high frequency voltage is applied between the active electrode(s) and one or more return electrode(s) such that at least a portion of the nucleus pulposus is ablated, and the volume of the disc's nucleus pulposus is decreased. After ablation of disc tissue at the first region of the intervertebral disc, other regions of the disc may be contacted with the at least one active electrode for ablation of disc tissue at the other regions of the disc. In one embodiment of the invention, axial translation of the at least one active electrode within the disc while applying the first high frequency voltage, leads to formation of a channel within the treated disc. The diameter of such a channel may be increased by rotating the at least one active electrode about the longitudinal axis of the shaft while applying the first high frequency voltage. Optionally, after a channel has been formed in the disc, disc tissue in the vicinity of the channel may be coagulated, or made necrotic, by applying a second high frequency voltage, wherein the second high frequency voltage may have different parameters as compared with the first high frequency voltage.
In another aspect, the present invention provides a method for treating an intervertebral disc, wherein the method involves providing an electrosurgical system including a probe having a shaft and a handle, the shaft having at least one active electrode located on the distal end portion of the shaft, and wherein the shaft distal end portion includes a pre-defined bias. The method further involves inserting the shaft distal end portion within the disc, and ablating at least a portion of the nucleus pulposus tissue from the disc such that the volume of the disc is decreased with minimal collateral damage to non-target tissue within the disc. The ablating step involves applying a high frequency voltage between the at least one active electrode and at least one return electrode. The high frequency voltage is sufficient to vaporize an electrically conductive fluid (e.g., a gel, isotonic saline, and/or tissue fluid) located between the at least one active electrode and the target tissue. Within the vaporized fluid a plasma is formed, and charged particles (e.g., electrons) are accelerated towards the nucleus pulposus to cause the molecular dissociation of nucleus pulposus tissue at the site to be ablated. This molecular dissociation is accompanied by the volumetric removal of disc tissue at the target site.
In one embodiment, inserting the shaft distal end portion in the disc involves advancing the shaft distal end portion via an introducer needle, the introducer needle having a lumen and a needle distal end, such that when the shaft distal end portion is advanced distally beyond the needle distal end, the at least one active electrode does not make contact with the needle distal end. One or more stages in the treatment or procedure may be performed under fluoroscopy to allow visualization of the shaft within the disc to be treated. Visualization of the shaft may be enhanced by inclusion of a radiopaque tracking device on the distal end of the shaft. The depth of penetration of the shaft into a disc can be monitored by one or more depth markings on the shaft.
In another aspect of the invention, the method further comprises retracting the shaft distal end portion proximally within the lumen of the introducer needle, wherein the at least one active electrode does not make contact with the needle distal end.
In another aspect of the invention, the shaft of the electrosurgical system includes a shield, and a distal insulating collar. In yet another aspect of the invention, the at least one active electrode includes an apical spike and a cusp. Applicants have found that an active electrode having an apical spike and a cusp promotes high current density in the vicinity of the active electrode.
For a further understanding of the nature and advantages of the invention, reference should be made to the following description taken in conjunction with the accompanying drawings.
The present invention provides systems and methods for selectively applying electrical energy to a target location within or on a patient's body, particularly including support tissue or other body structures in the spine. These procedures include treating interspinous tissue, degenerative discs, laminectomy/discectomy procedures for treating herniated discs, decompressive laminectomy for stenosis in the lumbosacral and cervical spine, localized tears or fissures in the annulus, nucleotomy, disc fusion procedures, medial facetectomy, posterior lumbosacral and cervical spine fusions, treatment of scoliosis associated with vertebral disease, foraminotomies to remove the roof of the intervertebral foramina to relieve nerve root compression and anterior cervical and lumbar discectomies. These procedures may be performed through open procedures, or using minimally invasive techniques, such as thoracoscopy, arthroscopy, laparascopy or the like.
The present invention involves techniques for treating disc abnormalities with RF energy. In some embodiments, RF energy is used to ablate, debulk and/or stiffen the tissue structure of the disc to reduce the volume of the disc, thereby relieving neck and back pain. In one aspect of the invention, spinal disc tissue is volumetrically removed or ablated to form holes, channels, divots or other spaces within the disc. In this procedure, a high frequency voltage difference is applied between one or more active electrode(s) and one or more return electrode(s) to develop high electric field intensities in the vicinity of the target tissue. The high electric field intensities adjacent the active electrode(s) lead to electric field induced molecular breakdown of target tissue through molecular dissociation (rather than thermal evaporation or carbonization). Applicant believes that the tissue structure is volumetrically removed through molecular disintegration of larger organic molecules into smaller molecules and/or atoms, such as hydrogen, oxygen, oxides of carbon, hydrocarbons and nitrogen compounds. This molecular disintegration completely removes the tissue structure, as opposed to dehydrating the tissue material by the removal of liquid within the cells of the tissue and extracellular fluids, as is typically the case with electrosurgical desiccation and vaporization.
The present invention also involves a system and method for treating the interspinous tissue (e.g., tendons, cartilage, synovial tissue in between the vertebrae, and other support tissue within and surrounding the vertebral column). In some embodiments, RF energy is used to heat and shrink the interspinous tissue to stabilize the vertebral column and reduce pain in the back and neck. In one aspect of the invention, an active electrode is positioned adjacent the interspinous tissue and the interspinous tissue is heated, preferably with RF energy, to a sufficient temperature to shrink the interspinous tissue. In a specific embodiment, a high frequency voltage difference is applied between one or more active electrode(s) and one or more return electrode(s) to develop high electric field intensities in the vicinity of the target tissue to controllably heat the target tissue.
The high electric field intensities may be generated by applying a high frequency voltage that is sufficient to vaporize an electrically conductive fluid over at least a portion of the active electrode(s) in the region between the distal tip of the active electrode(s) and the target tissue. The electrically conductive fluid may be a liquid or gas, such as isotonic saline, blood, extracellular or intracellular fluid, delivered to, or already present at, the target site, or a viscous fluid, such as a gel, applied to the target site. Since the vapor layer or vaporized region has a relatively high electrical impedance, it minimizes the current flow into the electrically conductive fluid. This ionization, under the conditions described herein, induces the discharge of energetic electrons and photons from the vapor layer and to the surface of the target tissue A more detailed description of this phenomena, termed Coblation® can be found in commonly assigned U.S. Pat. No. 5,697,882 the complete disclosure of which is incorporated herein by reference.
Applicant believes that the principle mechanism of tissue removal in the Coblation® mechanism of the present invention is energetic electrons or ions that have been energized in a plasma adjacent to the active electron(s). When a liquid is heated enough that atoms vaporize off the surface faster than they recondense, a gas is formed. When the gas is heated enough that the atoms collide with each other and knock their electrons off in the process, an ionized gas or plasma is formed (the so-called “fourth state of matter”). A more complete description of plasma can be found in Plasma Physics, by R. J. Goldston and P. H. Rutherford of the Plasma Physics Laboratory of Princeton University (1995), the complete disclosure of which is incorporated herein by reference. When the density of the vapor layer (or within a bubble formed in the electricity conducting liquid) becomes sufficiently low (i.e., less than approximately 1020 atoms/cm3 for aqueous solutions), the electron mean free path increases to enable subsequently injected electrons to cause impact ionization within these regions of low density (i.e., vapor layers or bubbles). Once the isotonic particles in the plasma layer have sufficient energy, they accelerate towards the target tissue. Energy evolved by the energetic electrons (e.g., 3.5 eV to 5 eV) can subsequently bombard a molecule and break its bonds, dissociating a molecule into free radicals, which then combine into final gaseous or liquid species.
Plasmas may be formed by heating a gas and ionizing the gas by driving an electric current through it, or by shining radio waves into the gas. Generally, these methods of plasma formation give energy to free electrons in the plasma directly, and then electron-atom collisions liberate more electrons, and the process cascades until the desired degree of ionization is achieved. Often, the electrons carry the electrical current or absorb the radio waves and, therefore, are hotter than the ions. Thus, in applicant's invention, the electrons, which are carried away from the tissue towards the return electrode, carry most of the plasma's heat with them, allowing the ions to break apart the tissue molecules in a substantially non-thermal manner.
In some embodiments, the present invention applies high frequency (RF) electrical energy in an electrically conducting media environment to shrink or remove (i.e., resect, cut, or ablate) a tissue structure and to seal transected vessels within the region of the target tissue. The present invention may also be useful for sealing larger arterial vessels, e.g., on the order of about 1 mm in diameter. In some embodiments, a high frequency power supply is provided having an ablation mode, wherein a first voltage is applied to an active electrode sufficient to effect molecular dissociation or disintegration of the tissue, and a coagulation mode, wherein a second, lower voltage is applied to an active electrode (either the same or a different electrode) sufficient to heat, shrink, and/or achieve hemostasis of severed vessels within the tissue. In other embodiments, an electrosurgical instrument is provided having one or more coagulation electrode(s) configured for sealing a severed vessel, such as an arterial vessel, and one or more active electrodes configured for either contracting the collagen fibers within the tissue or removing (ablating) the tissue, e.g., by applying sufficient energy to the tissue to effect molecular dissociation. In the latter embodiments, the coagulation electrode(s) may be configured such that a single voltage can be applied to coagulate with the coagulation electrode(s), and to ablate or shrink with the active electrode(s). In other embodiments, the power supply is combined with the coagulation instrument such that the coagulation electrode is used when the power supply is in the coagulation mode (low voltage), and the active electrode(s) are used when the power supply is in the ablation mode (higher voltage).
In one method of the present invention, one or more active electrodes are brought into close proximity to tissue at a target site, and the power supply is activated in the ablation mode such that sufficient voltage is applied between the active electrodes and the return electrode to volumetrically remove the tissue through molecular dissociation, as described below. During this process, vessels within the tissue will be severed. Smaller vessels will be automatically sealed with the system and method of the present invention. Larger vessels, and those with a higher flow rate, such as arterial vessels, may not be automatically sealed in the ablation mode. In these cases, the severed vessels may be sealed by activating a control (e.g., a foot pedal) to reduce the voltage of the power supply into the coagulation mode. In this mode, the active electrodes may be pressed against the severed vessel to provide sealing and/or coagulation of the vessel. Alternatively, a coagulation electrode located on the same or a different instrument may be pressed against the severed vessel. Once the vessel is adequately sealed, the surgeon activates a control (e.g., another foot pedal) to increase the voltage of the power supply back into the ablation mode.
In another aspect, the present invention may be used to shrink or contract collagen connective tissue which supports the vertebral column or connective tissue within the disc. In these procedures, the RF energy heats the tissue directly by virtue of the electrical current flow therethrough, and/or indirectly through the exposure of the tissue to fluid heated by RF energy, to elevate the tissue temperature from normal body temperature (e.g., 37° C.) to temperatures in the range of 45° C. to 90° C., preferably in the range from about 60° C. to 70° C. Thermal shrinkage of collagen fibers occurs within a small temperature range which, for mammalian collagens is in the range from 60° C. to 70° C. (Deak, G., et al., “The Thermal Shrinkage Process of Collagen Fibres as Revealed by Polarization Optical Analysis of Topoptical Staining Reactions,” Acta Morphological Acad. Sci. of Hungary, Vol., 15(2), pp. 195-208, 1967). Collagen fibers typically undergo thermal shrinkage in the range of 60° C. to about 70° C. Previously reported research has attributed thermal shrinkage of collagen to the cleaving of the internal stabilizing cross-linkages within the collagen matrix (Deak, ibid). It has also been reported that when the collagen temperature is increased above 70° C., the collagen matrix begins to relax again and the shrinkage effect is reversed resulting in no net shrinkage (Allain, J. C., et al., “Isometric Tensions Developed During the Hydrothermal Swelling of Rat Skin,” Connective Tissue Research, Vol. 7, pp 127-133, 1980), the complete disclosure of which is incorporated by reference. Consequently, the controlled heating of tissue to a precise depth is critical to the achievement of therapeutic collagen shrinkage. A more detailed description of collagen shrinkage can be found in U.S. patent application Ser. No. 08/942,580 filed on Oct. 2, 1997, the complete disclosure of which is incorporated by reference.
The preferred depth of heating to effect the shrinkage of collagen in the heated region (i.e., the depth to which the tissue is elevated to temperatures between 60° C. to 70° C.) generally depends on (1) the thickness of the target tissue, (2) the location of nearby structures (e.g., nerves) that should not be exposed to damaging temperatures, and/or (3) the location of the collagen tissue layer within which therapeutic shrinkage is to be effected. The depth of heating is usually in the range from 1.0 mm to 5.0 mm. In some embodiments of the present invention, the tissue is purposely damaged in a thermal heating mode to create necrosed or scarred tissue at the tissue surface. The high frequency voltage in the thermal heating mode is below the threshold of ablation as described above, but sufficient to cause some thermal damage to the tissue immediately surrounding the electrodes without vaporizing or otherwise debulking this tissue in situ. Typically, it is desired to achieve a tissue temperature in the range of about 60° C. to 100° C. to a depth of about 0.2 mm to 5 mm, usually about 1 mm to 2 mm. The voltage required for this thermal damage will partly depend on the electrode configurations, the conductivity of the area immediately surrounding the electrodes, the time period in which the voltage is applied and the depth of tissue damage desired. With the electrode configurations described in this application (e.g., FIGS. 15A-15D), the voltage level for thermal heating will usually be in the range of about 20 volts rms to 300 volts rms, preferably about 60 volts rms to 200 volts rms. The peak-to-peak voltages for thermal heating with a square wave form having a crest factor of about 2 are typically in the range of about 40 volts peak-to-peak to 600 volts peak-to-peak, preferably about 120 volts peak-to-peak to 400 volts peak-to-peak. In some embodiments, capacitors or other electrical elements may be used to increase the crest factor up to 10. The higher the voltage is within this range, the less time required. If the voltage is too high, however, the surface tissue may be vaporized, debulked or ablated, which is generally undesirable.
In yet another embodiment, the present invention may be used for treating degenerative discs with fissures or tears. In these embodiments, the active and return electrode(s) are positioned in or around the inner wall of the disc annulus such that the active electrode is adjacent to the fissure. High frequency voltage is applied between the active and return electrodes to heat the fissure and shrink the collagen fibers and create a seal or weld within the inner wall, thereby helping to close the fissure in the annulus. In these embodiments, the return electrode will typically be positioned proximally from the active electrode(s) on the instrument shaft, and an electrically conductive fluid will be applied to the target site to create the necessary current path between the active and return electrodes. In alternative embodiments, the disc tissue may complete this electrically conductive path.
The present invention is also useful for removing or ablating tissue around nerves, such as spinal, peripheral or cranial nerves. One of the significant drawbacks with the prior art shavers or microdebriders, conventional electrosurgical devices and lasers is that these devices do not differentiate between the target tissue and the surrounding nerves or bone. Therefore, the surgeon must be extremely careful during these procedures to avoid damage to the bone or nerves within and around the target site. In the present invention, the Coblation® process for removing tissue results in extremely small depths of collateral tissue damage as discussed above. This allows the surgeon to remove tissue close to a nerve without causing collateral damage to the nerve fibers.
In addition to the generally precise nature of the novel mechanisms of the present invention, applicant has discovered an additional method of ensuring that adjacent nerves are not damaged during tissue removal. According to the present invention, systems and methods are provided for distinguishing between the fatty tissue immediately surrounding nerve fibers and the normal tissue that is to be removed during the procedure. Peripheral nerves usually comprise a connective tissue sheath, or epineurium, enclosing the bundles of nerve fibers, each bundle being surrounded by its own sheath of connective tissue (the perineurium) to protect these nerve fibers. The outer protective tissue sheath or epineurium typically comprises a fatty tissue (e.g., adipose tissue) having substantially different electrical properties than the normal target tissue, such as the turbinates, polyps, mucus tissue or the like, that are, for example, removed from the nose during sinus procedures. The system of the present invention measures the electrical properties of the tissue at the tip of the probe with one or more active electrode(s). These electrical properties may include electrical conductivity at one, several or a range of frequencies (e.g., in the range from 1 kHz to 100 MHz), dielectric constant, capacitance or combinations of these. In this embodiment, an audible signal may be produced when the sensing electrode(s) at the tip of the probe detects the fatty tissue surrounding a nerve, or direct feedback control can be provided to only supply power to the active electrode(s) either individually or to the complete array of electrodes, if and when the tissue encountered at the tip or working end of the probe is normal tissue based on the measured electrical properties.
In one embodiment, the current limiting elements (discussed in detail above) are configured such that the active electrodes will shut down or turn off when the electrical impedance reaches a threshold level. When this threshold level is set to the impedance of the fatty tissue surrounding nerves, the active electrodes will shut off whenever they come in contact with, or in close proximity to, nerves. Meanwhile, the other active electrodes, which are in contact with or in close proximity to tissue, will continue to conduct electric current to the return electrode. This selective ablation or removal of lower impedance tissue in combination with the Coblation® mechanism of the present invention allows the surgeon to precisely remove tissue around nerves or bone. Applicant has found that the present invention is capable of volumetrically removing tissue closely adjacent to nerves without impairment the function of the nerves, and without significantly damaging the tissue of the epineurium. One of the significant drawbacks with the prior art microdebriders, conventional electrosurgical devices and lasers is that these devices do not differentiate between the target tissue and the surrounding nerves or bone. Therefore, the surgeon must be extremely careful during these procedures to avoid damage to the bone or nerves within and around the nasal cavity. In the present invention, the Coblation® process for removing tissue results in extremely small depths of collateral tissue damage as discussed above. This allows the surgeon to remove tissue close to a nerve without causing collateral damage to the nerve fibers.
In addition to the above, applicant has discovered that the Coblation® mechanism of the present invention can be manipulated to ablate or remove certain tissue structures, while having little effect on other tissue structures. As discussed above, the present invention uses a technique of vaporizing electrically conductive fluid to form a plasma layer or pocket around the active electrode(s), and then inducing the discharge of energy from this plasma or vapor layer to break the molecular bonds of the tissue structure. Based on initial experiments, applicants believe that the free electrons within the ionized vapor layer are accelerated in the high electric fields near the electrode tip(s). When the density of the vapor layer (or within a bubble formed in the electrically conducting liquid) becomes sufficiently low (i.e., less than approximately 1020 atoms/cm3 for aqueous solutions), the electron mean free path increases to enable subsequently injected electrons to cause impact ionization within these regions of low density (i.e., vapor layers or bubbles). Energy evolved by the energetic electrons (e.g., 4 eV to 5 eV) can subsequently bombard a molecule and break its bonds, dissociating a molecule into free radicals, which then combine into final gaseous or liquid species.
The energy evolved by the energetic electrons may be varied by adjusting a variety of factors, such as: the number of active electrodes; electrode size and spacing; electrode surface area; asperities and sharp edges on the electrode surfaces; electrode materials; applied voltage and power; current limiting means, such as inductors; electrical conductivity of the fluid in contact with the electrodes; density of the fluid; and other factors. Accordingly, these factors can be manipulated to control the energy level of the excited electrons. Since different tissue structures have different molecular bonds, the present invention can be configured to break the molecular bonds of certain tissue, while having too low an energy to break the molecular bonds of other tissue. For example, fatty tissue, (e.g., adipose) tissue has double bonds that require a substantially higher energy level than 4 eV to 5 eV to break (typically on the order of about 8 eV). Accordingly, the present invention in its current configuration generally does not ablate or remove such fatty tissue. However, the present invention may be used to effectively ablate cells to release the inner fat content in a liquid form. Of course, factors may be changed such that these double bonds can also be broken in a similar fashion as the single bonds (e.g., increasing voltage or changing the electrode configuration to increase the current density at the electrode tips). A more complete description of this phenomena can be found in co-pending U.S. patent application Ser. No. 09/032,375, filed Feb. 27, 1998, the complete disclosure of which is incorporated herein by reference.
In yet other embodiments, the present invention provides systems, apparatus and methods for selectively removing tumors, e.g., facial tumors, or other undesirable body structures while minimizing the spread of viable cells from the tumor. Conventional techniques for removing such tumors generally result in the production of smoke in the surgical setting, termed an electrosurgical or laser plume, which can spread intact, viable bacterial or viral particles from the tumor or lesion to the surgical team or to other portions of the patient's body. This potential spread of viable cells or particles has resulted in increased concerns over the proliferation of certain debilitating and fatal diseases, such as hepatitis, herpes, HIV and papillomavirus. In the present invention, high frequency voltage is applied between the active electrode(s) and one or more return electrode(s) to volumetrically remove at least a portion of the tissue cells in the tumor through the dissociation or disintegration of organic molecules into non-viable atoms and molecules. Specifically, the present invention converts the solid tissue cells into non-condensable gases that are no longer intact or viable, and thus, not capable of spreading viable tumor particles to other portions of the patient's brain or to the surgical staff. The high frequency voltage is preferably selected to effect controlled removal of these tissue cells while minimizing substantial tissue necrosis to surrounding or underlying tissue. A more complete description of this phenomena can be found in co-pending U.S. patent application Ser. No. 09/109,219, filed Jun. 30, 1998, the complete disclosure of which is incorporated herein by reference.
The electrosurgical probe or catheter of the present invention can comprise a shaft or a handpiece having a proximal end and a distal end which supports one or more active electrode(s). The shaft or handpiece may assume a wide variety of configurations, with the primary purpose being to mechanically support the active electrode and permit the treating physician to manipulate the electrode from a proximal end of the shaft. The shaft may be rigid or flexible, with flexible shafts optionally being combined with a generally rigid external tube for mechanical support. Flexible shafts may be combined with pull wires, shape memory actuators, and other known mechanisms for effecting selective deflection of the distal end of the shaft to facilitate positioning of the electrode array. The shaft will usually include a plurality of wires or other conductive elements running axially therethrough to permit connection of the electrode array to a connector at the proximal end of the shaft.
For endoscopic procedures within the spine, the shaft will have a suitable diameter and length to allow the surgeon to reach the target site (e.g., a disc or vertebra) by delivering the shaft through the thoracic cavity, the abdomen or the like. Thus, the shaft will usually have a length in the range of about 5.0 cm to 30.0 cm, and a diameter in the range of about 0.2 mm to about 20 mm. Alternatively, the shaft may be delivered directly through the patient's back in a posterior approach, which would considerably reduce the required length of the shaft. In any of these embodiments, the shaft may also be introduced through rigid or flexible endoscopes. Alternatively, the shaft may be a flexible catheter that is introduced through a percutaneous penetration in the patient. Specific shaft designs will be described in detail in connection with the figures hereinafter.
In an alternative embodiment, the probe may comprise a long, thin needle (e.g., on the order of about 1 mm in diameter or less) that can be percutaneously introduced through the patient's back directly into the spine. The needle will include one or more active electrode(s) for applying electrical energy to tissues within the spine. The needle may include one or more return electrode(s), or the return electrode may be positioned on the patient's back, as a dispersive pad. In either embodiment, sufficient electrical energy is applied through the needle to the active electrode(s) to either shrink the collagen fibers within the spinal disc, to ablate tissue within the disc, or to shrink support fibers surrounding the vertebrae.
The electrosurgical instrument may also be a catheter that is delivered percutaneously and/or endoluminally into the patient by insertion through a conventional or specialized guide catheter, or the invention may include a catheter having an active electrode or electrode array integral with its distal end. The catheter shaft may be rigid or flexible, with flexible shafts optionally being combined with a generally rigid external tube for mechanical support. Flexible shafts may be combined with pull wires, shape memory actuators, and other known mechanisms for effecting selective deflection of the distal end of the shaft to facilitate positioning of the electrode or electrode array. The catheter shaft will usually include a plurality of wires or other conductive elements running axially therethrough to permit connection of the electrode or electrode array and the return electrode to a connector at the proximal end of the catheter shaft. The catheter shaft may include a guide wire for guiding the catheter to the target site, or the catheter may comprise a steerable guide catheter. The catheter may also include a substantially rigid distal end portion to increase the torque control of the distal end portion as the catheter is advanced further into the patient's body. Specific shaft designs will be described in detail in connection with the figures hereinafter.
The active electrode(s) are preferably supported within or by an inorganic insulating support positioned near the distal end of the instrument shaft. The return electrode may be located on the instrument shaft, on another instrument or on the external surface of the patient (i.e., a dispersive pad). The close proximity of nerves and other sensitive tissue in and around the spinal cord, however, makes a bipolar design more preferable because this minimizes the current flow through non-target tissue and surrounding nerves. Accordingly, the return electrode is preferably either integrated with the instrument body, or another instrument located in close proximity thereto. The proximal end of the instrument(s) will include the appropriate electrical connections for coupling the return electrode(s) and the active electrode(s) to a high frequency power supply, such as an electrosurgical generator.
In some embodiments, the active electrode(s) have an active portion or surface with surface geometries shaped to promote the electric field intensity and associated current density along the leading edges of the electrodes. Suitable surface geometries may be obtained by creating electrode shapes that include preferential sharp edges, or by creating asperities or other surface roughness on the active surface(s) of the electrodes. Electrode shapes according to the present invention can include the use of formed wire (e.g., by drawing round wire through a shaping die) to form electrodes with a variety of cross-sectional shapes, such as square, rectangular, L or V shaped, or the like. Electrode edges may also be created by removing a portion of the elongate metal electrode to reshape the cross-section. For example, material can be ground along the length of a round or hollow wire electrode to form D or C shaped wires, respectively, with edges facing in the cutting direction. Alternatively, material can be removed at closely spaced intervals along the electrode length to form transverse grooves, slots, threads or the like along the electrodes.
Additionally or alternatively, the active electrode surface(s) may be modified through chemical, electrochemical or abrasive methods to create a multiplicity of surface asperities on the electrode surface. These surface asperities will promote high electric field intensities between the active electrode surface(s) and the target tissue to facilitate ablation or cutting of the tissue. For example, surface asperities may be created by etching the active electrodes with etchants having a pH less than 7.0 or by using a high velocity stream of abrasive particles (e.g., grit blasting) to create asperities on the surface of an elongated electrode. A more detailed description of such electrode configuration can be found in U.S. Pat. No. 5,843,019, the complete disclosure of which is incorporated herein by reference.
The return electrode is typically spaced proximally from the active electrode(s) a suitable distance to avoid electrical shorting between the active and return electrodes in the presence of electrically conductive fluid. In most of the embodiments described herein, the distal edge of the exposed surface of the return electrode is spaced about0.5 mm to 25 mm from the proximal edge of the exposed surface of the active electrode(s), preferably about 1.0 mm to 5.0 mm. Of course, this distance may vary with different voltage ranges, conductive fluids, and depending on the proximity of tissue structures to active and return electrodes. The return electrode will typically have an exposed length in the range of about 1 mm to 20 mm.
The current flow path between the active electrodes and the return electrode(s) may be generated by submerging the tissue site in an electrical conducting fluid (e.g., within a viscous fluid, such as an electrically conductive gel) or by directing an electrically conductive fluid along a fluid path to the target site (i.e., a liquid, such as isotonic saline, hypotonic saline or a gas, such as argon). The conductive gel may also be delivered to the target site to achieve a slower more controlled delivery rate of conductive fluid. In addition, the viscous nature of the gel may allow the surgeon to more easily contain the gel around the target site (e.g., rather than attempting to contain isotonic saline). A more complete description of an exemplary method of directing electrically conductive fluid between the active and return electrodes is described in U.S. Pat. No. 5,697,281, previously incorporated herein by reference. Alternatively, the body's natural conductive fluids, such as blood or extracellular saline, may be sufficient to establish a conductive path between the return electrode(s) and the active electrode(s) and to provide the conditions for establishing a vapor layer, as described above. However, conductive fluid that is introduced into the patient is generally preferred over blood because blood will tend to coagulate at certain temperatures. In addition, the patient's blood may not have sufficient electrical conductivity to adequately form a plasma in some applications. Advantageously, a liquid electrically conductive fluid (e.g., isotonic saline) may be used to concurrently “bathe” the target tissue surface to provide an additional means for removing any tissue, and to cool the region of the target tissue ablated in the previous moment.
The power supply, or generator, may include a fluid interlock for interrupting power to the active electrode(s) when there is insufficient conductive fluid around the active electrode(s). This ensures that the instrument will not be activated when conductive fluid is not present, minimizing the tissue damage that may otherwise occur. A more complete description of such a fluid interlock can be found in commonly assigned, co-pending U.S. applicant Ser. No. 09/058,336, filed Apr. 10, 1998, the complete disclosure of which is incorporated herein by reference.
In some procedures, it may also be necessary to retrieve or aspirate the electrically conductive fluid and/or the non-condensable gaseous products of ablation. In addition, it may be desirable to aspirate small pieces of tissue or other body structures that are not completely disintegrated by the high frequency energy, or other fluids at the target site, such as blood, mucus, the gaseous products of ablation, etc. Accordingly, the system of the present invention may include one or more suction lumen(s) in the instrument, or on another instrument, coupled to a suitable vacuum source for aspirating fluids from the target site. In addition, the invention may include one or more aspiration electrode(s) coupled to the distal end of the suction lumen for ablating, or at least reducing the volume of, non-ablated tissue fragments that are aspirated into the lumen. The aspiration electrode(s) function mainly to inhibit clogging of the lumen that may otherwise occur as larger tissue fragments are drawn therein. The aspiration electron(s) may be different from the ablation active electrode(s), or the same electrode(s) may serve both functions. A more complete description of instruments incorporating aspiration electrode(s) can be found in commonly assigned, co-pending U.S. patent application Ser. No. 09/010,382 filed Jan. 21, 1998, the complete disclosure of which is incorporated herein by reference.
As an alternative or in addition to suction, it may be desirable to contain the excess electrically conductive fluid, tissue fragments and/or gaseous products of ablation at or near the target site with a containment apparatus, such as a basket, retractable sheath, or the like. This embodiment has the advantage of ensuring that the conductive fluid, tissue fragments or ablation products do not flow through the patient's vasculature or into other portions of the body. In addition, it may be desirable to limit the amount of suction to limit the undesirable effect suction may have on hemostasis of severed blood vessels.
The present invention may use a single active electrode or an array of active electrodes spaced around the distal surface of a catheter or probe. In the latter embodiment, the electrode array usually includes a plurality of independently current-limited and/or power-controlled active electrodes to apply electrical energy selectively to the target tissue while limiting the unwanted application of electrical energy to the surrounding tissue and environment resulting from power dissipation into surrounding electrically conductive fluids, such as blood, normal saline, and the like. The active electrodes may be independently current-limited by isolating the terminals from each other and connecting each terminal to a separate power source that is isolated from the other active electrodes. Alternatively, the active electrodes may be connected to each other at either the proximal or distal ends of the catheter to form a single wire that couples to a power source.
In one configuration, each individual active electrode in the electrode array is electrically insulated from all other active electrodes in the array within said instrument and is connected to a power source which is isolated from each of the other active electrodes in the array or to circuitry which limits or interrupts current flow to the active electrode when low resistivity material (e.g., blood, electrically conductive saline irrigant or electrically conductive gel) causes a lower impedance path between the return electrode and the individual active electrode. The isolated power sources for each individual active electrode may be separate power supply circuits having internal impedance characteristics which limit power to the associated active electrode when a low impendance return path is encountered. By way of example, the isolated power source may be a user selectable constant current source. In this embodiment, lower impedance paths will automatically result in lower resistive heating levels since the heating is proportional to the square of the operating current times the impedance. Alternatively, a single power source may be connected to each of the active electrodes through independently actuatable switches, or by independent current limiting elements, such as inductors, capacitors, resistors and/or combinations thereof. The current limiting elements may be provided in the instrument, connectors, cable, controller, or along the conductive path from the controller to the distal tip of the instrument. Alternatively, the resistance and/or capacitance may occur on the surface of the active electrode(s) due to oxide layers which form selected active electrodes (e.g., titanium or a resistive coating on the surface of metal, such as platinum).
The tip region of the instrument may comprise many independent active electrodes designed to deliver electrical energy in the vicinity of the tip. The selective application of electrical energy to the conductive fluid is achieved by connecting each individual active electrode and the return electrode to a power source having independently controlled or current limited channels. The return electrode(s) may comprise a single tubular member of conductive material proximal to the electrode array at the tip which also serves as a conduit for the supply of the electrically conductive fluid between the active and return electrodes. Alternatively, the instrument may comprise an array of return electrodes at the distal tip of the instrument (together with the active electrodes) to maintain the electric current at the tip. The application of high frequency voltage between the return electrode(s) and the electrode array results in the generation of high electric field intensities at the distal tips of the active electrodes with conduction of high frequency current from each individual active electrode to the return electrode. The current flow from each individual active electrode to the return electrode(s) is controlled by either active or passive means, or a combination thereof, to deliver electrical energy to the surrounding conductive fluid while minimizing energy delivery to surrounding (non-target) tissue.
The application of a high frequency voltage between the return electrode(s) and the active electrode(s) for appropriate time intervals effects shrinking, cutting, removing, ablating, shaping, contracting or otherwise modifying the target tissue. In some embodiments of the present invention, the tissue volume over which energy is dissipated (i.e., a high current density exists) may be more precisely controlled, for example, by the use of a multiplicity of small active electrodes whose effective diameters or principle dimensions range from about 10 mm to 0.01 mm, preferably from about 2 mm to 0.05 mm, and more preferably from about 1 mm to 0.1 mm. In this embodiment, electrode areas for both circular and non-circular terminals will have a contact area (per active electrode) below 50 mm2 for electrode arrays and as large as 75 mm2 for single electrode embodiments. In multiple electrode array embodiments, the contact area of each active electrode is typically in the range from 0.0001 mm2 to 1 mm2, and more preferably from 0.001 mm2 to 0.5 mm2. The circumscribed area of the electrode array or active electrode is in the range from 0.25 mm2 to 75 mm2, preferably from 0.5 mm2 to 40 mm2. In multiple electrode embodiments, the array will usually include at least two isolated active electrodes, often at least five active electrodes, often greater than 10 active electrodes and even 50 or more active electrodes, disposed over the distal contact surfaces on the shaft. The use of small diameter active electrodes increases the electric field intensity and reduces the extent or depth of tissue heating as a consequence of the divergence of current flux lines which emanate from the exposed surface of each active electrode.
The area of the tissue treatment surface can vary widely, and the tissue treatment surface can assume a variety of geometries, with particular areas and geometries being selected for specific applications. The geometries can be planar, concave, convex, hemispherical, conical, linear “inline” array or virtually any other regular or irregular shape. Most commonly, the active electrode(s) or active electrode(s) will be formed at the distal tip of the electrosurgical instrument shaft, frequently being planar, disk-shaped, or hemispherical surfaces for use in reshaping procedures or being linear arrays for use in cutting. Alternatively or additionally, the active electrode(s) may be formed on lateral surfaces of the electrosurgical instrument shaft (e.g., in the manner of a spatula), facilitating access to certain body structures in endoscopic procedures.
It should be clearly understood that the invention is not limited to electrically isolated active electrodes, or even to a plurality of active electrodes. For example, the array of active electrodes may be connected to a single lead that extends through the catheter shaft to a power source of high frequency current. Alternatively, the instrument may incorporate a single electrode that extends directly through the catheter shaft or is connected to a single lead that extends to the power source. The active electrode(s) may have ball shapes (e.g., for tissue vaporization and desiccation), twizzle shapes (for vaporization and needle-like cutting), spring shapes (for rapid tissue debulking and desiccation), twisted metal shapes, annular or solid tube shapes or the like. Alternatively, the electrode(s) may comprise a plurality of filaments, rigid or flexible brush electrode(s) (for debulking a tumor, such as a fibroid, bladder tumor or a prostate adenoma), side-effect brush electrode(s) on a lateral surface of the shaft, coiled electrode(s) or the like.
In some embodiments, the electrode support and the fluid outlet may be recessed from an outer surface of the instrument or handpiece to confine the electrically conductive fluid to the region immediately surrounding the electrode support. In addition, the shaft may be shaped so as to form a cavity around the electrode support and the fluid outlet. This helps to assure that the electrically conductive fluid will remain in contact with the active electrode(s) and the return electrode(s) to maintain the conductive path therebetween. In addition, this will help to maintain a vapor layer and subsequent plasma layer between the active electrode(s) and the tissue at the treatment site throughout the procedure, which reduces the thermal damage that might otherwise occur if the vapor layer were extinguished due to a lack of conductive fluid. Provision of the electrically conductive fluid around the target site also helps to maintain the tissue temperature at desired levels.
In other embodiments, the active electrodes are spaced from the tissue a sufficient distance to minimize or avoid contact between the tissue and the vapor layer formed around the active electrodes. In these embodiments, contact between the heated electrons in the vapor layer and the tissue is minimized as these electrons travel from the vapor layer back through the conductive fluid to the return electrode. The ions within the plasma, however, will have sufficient energy, under certain conditions such as higher voltage levels, to accelerate beyond the vapor layer to the tissue. Thus, the tissue bonds are dissociated or broken as in previous embodiments, while minimizing the electron flow, and thus the thermal energy, in contact with the tissue.
The electrically conductive fluid should have a threshold conductivity to provide a suitable conductive path between the return electrode and the active electrode(s). The electrical conductivity of the fluid (in units of millisiemens per centimeter or mS/cm) will usually be greater than 0.2 mS/cm, preferably will be greater than 2 mS/cm and more preferably greater than 10 mS/cm. In an exemplary embodiment, the electrically conductive fluid is isotonic saline, which has a conductivity of about 17 mS/cm. Applicant has found that a more conductive fluid, or one with a higher ionic concentration, will usually provide a more aggressive ablation rate. For example, a saline solution with higher levels of sodium chloride than conventional saline (which is on the order of about 0.9% sodium chloride) e.g., on the order of greater than 1% or between about 3% and 20%, may be desirable. Alternatively, the invention may be used with different types of conductive fluids that increase the power of the plasma layer by, for example, increasing the quantity of ions in the plasma, or by providing ions that have higher energy levels than sodium ions. For example, the present invention may be used with elements other than sodium, such as potassium, magnesium, calcium and other metals near the left end of the periodic chart. In addition, other electronegative elements may be used in place of chlorine, such as fluorine.
The voltage difference applied between applied between the return electrode(s) and the active electrode(s) will be at high or radio frequency, typically between about 5 kHz and 20 MHz, usually being between about 30 kHz and 2.5 MHz, preferably being between about 50 kHz and 500 kHz, often less than 350 kHz , and often between about 100 kHz and 200 kHz. In some applications, applicant has found that a frequency of about 100 kHz is useful because the tissue impedance is much greater at this frequency. In other applications, such as procedures in or around the heart or head and neck, higher frequencies may be desirable (e.g., 400-600 kHz) to minimize low frequency current flow into the heart or the nerves of the head and neck. The RMS (root mean square) voltage applied will usually be in the range from about 5 volts to 1000 volts, preferably being in the range from about 10 volts to 500 volts, often between about 150 volts to 400 volts depending on the active electrode size, the operating frequency and the operation mode of the particular procedure or desired effect on the tissue (i.e., contraction, coagulation, cutting or ablation). Typically, the peak-to-peak voltage for ablation or cutting with a square wave form will be in the range of 10 volts to 2000 volts and preferably in the range of 100 volts to 1800 volts and more preferably in the range of about 300 volts to 1500 volts, often in the range of about 300 volts to 800 volts peak to peak (again, depending on the electrode size, number of electrons, the operating frequency and the operation mode). Lower peak-to-peak voltages will be used for tissue coagulation, thermal heating of tissue, or collagen contraction and will typically be in the range from 50 to 1500, preferably 100 to 1000 and more preferably 120 to 400 volts peak-to-peak (again, these values are computed using a square wave form). Higher peak-to-peak voltages, e.g., greater than about 800 volts peak-to-peak, may be desirable for ablation of harder material, such as bone, depending on other factors, such as the electrode geometries and the composition of the conductive fluid.
As discussed above, the voltage is usually delivered in a series of voltage pulses or alternating current of time varying voltage amplitude with a sufficiently high frequency (e.g., on the order of 5 kHz to 20 MHz) such that the voltage is effectively applied continuously (as compared with e.g., lasers claiming small depths of necrosis, which are generally pulsed about 10 Hz to 20 Hz). In addition, the duty cycle (i.e., cumulative time in any one-second interval that energy is applied) is on the order of about 50% for the present invention, as compared with pulsed lasers which typically have a duty cycle of about 0.0001%.
The preferred power source of the present invention delivers a high frequency current selectable to generate average power levels ranging from several milliwatts to tens of watts per electrode, depending on the volume of target tissue being treated, and/or the maximum allowed temperature selected for the instrument tip. The power source allows the user to select the voltage level according to the specific requirements of a particular neurosurgery procedure, cardiac surgery, arthroscopic surgery, dermatological procedure, ophthalmic procedures, open surgery or other endoscopic surgery procedure. For cardiac procedures and potentially for neurosurgery, the power source may have an additional filter, for filtering leakage voltages at frequencies below 100 kHz, particularly voltages around 60 kHz. Alternatively, a power source having a higher operating frequency, e.g., 300 kHz to 600 kHz may be used in certain procedures in which stray low frequency currents may be problematic. A description of one suitable power source can be found in co-pending patent application Ser. Nos. 09/058,571 and 09/058,336, filed Apr. 10, 1998, the complete disclosure of both applications are incorporated herein by reference for all purposes.
The power source may be current limited or otherwise controlled so that undesired heating of the target tissue or surrounding (non-target) tissue does not occur. In a presently preferred embodiment of the present invention, current limiting inductors are placed in series with each independent active electrode, where the inductance of the inductor is in the range of 10 uH to 50,000 uH, depending on the electrical properties of the target tissue, the desired tissue heating rate and the operating frequency. Alternatively, capacitor-inductor (LC) circuit structures may be employed, as described previously in U.S. Pat. No. 5,697,909, the complete disclosure of which is incorporated herein by reference. Additionally, current limiting resistors may be selected. Preferably, these resistors will have a large positive temperature coefficient of resistance so that, as the current level begins to rise for any individual active electrode in contact with a low resistance medium (e.g., saline irrigant or blood), the resistance of the current limiting resistor increases significantly, thereby minimizing the power delivery from said active electrode into the low resistance medium (e.g., saline irrigant or blood).
Referring to
As shown, probe 10 generally includes a proximal handle 19 and an elongate shaft 18 having an array 12 of active electrodes 58 at its distal end. A connecting cable 34 has a connector 26 for electrically coupling the active electrodes 58 to power supply 28. The active electrodes 58 are electrically isolated from each other and each of electrodes 58 is connected to an active or passive control network within power supply 28 by means of a plurality of individually insulated conductors (not shown). A fluid supply tube 15 is connected to a fluid tube 14 of probe 10 for supplying electrically conductive fluid 50 to the target site. Fluid supply tube 15 may be connected to a suitable pump (not shown), if desired.
Power supply 28 has an operator controllable voltage level adjustment 30 to change the applied voltage level, which is observable at a voltage level display 32. Power supply 28 also includes first, second and third foot pedals 37, 38, 39 and a cable 36 which is removably coupled to power supply 28. The foot pedals 37, 38, 39 allow the surgeon to remotely adjust the energy level applied to active electrodes 58. In an exemplary embodiment, first foot pedal 37 is used to place the power supply into the “ablation” mode and second foot pedal 38 places power supply 28 into the “sub-ablation” mode (e.g., for coagulation or contraction of tissue). The third foot pedal 39 allows the user to adjust the voltage level within the “ablation” mode. In the ablation mode, a sufficient voltage is applied to the active electrodes to establish the requisite conditions for molecular dissociation of the tissue (i.e., vaporizing a portion of the electrically conductive fluid, ionizing charged particles within the vapor layer and accelerating these charged particles against the tissue). As discussed above, the requisite voltage level for ablation will vary depending on the number, size, shape and spacing of the electrodes, the distance in which the electrodes extend from the support member, etc. Once the surgeon places the power supply in the “ablation” mode, voltage level adjustment 30 or third foot pedal 39 may be used to adjust the voltage level to adjust the degree or aggressiveness of the ablation.
Of course, it will be recognized that the voltage and modality of the power supply may be controlled by other input devices. However, applicant has found that foot pedals are convenient methods of controlling the power supply while manipulating the probe during a surgical procedure.
In the subablation mode, the power supply 28 applies a low enough voltage to the active electrodes to avoid vaporization of the electrically conductive fluid and subsequent molecular dissociation of the tissue. The surgeon may automatically toggle the power supply between the ablation and sub-ablation modes by alternatively stepping on foot pedals 37, 38, respectively. In some embodiments, this allows the surgeon to quickly move between coagulation/thermal heating and ablation in situ, without having to remove his/her concentration from the surgical field or without having to request an assistant to switch the power supply. By way of example, as the surgeon is sculpting soft tissue in the ablation mode, the probe typically will simultaneously seal and/or coagulation small severed vessels within the tissue. However, larger vessels, or vessels with high fluid pressures (e.g., arterial vessels) may not be sealed in the ablation mode. Accordingly, the surgeon can simply step on foot pedal 38, automatically lowering the voltage level below the threshold level for ablation, and apply sufficient pressure onto the severed vessel for a sufficient period of time to seal and/or coagulate the vessel. After this is completed, the surgeon may quickly move back into the ablation mode by stepping on foot pedal 37.
Referring now to
The preferred power source of the present invention delivers a high frequency current selectable to generate average power levels ranging from several milliwatts to tens of watts per electrode, depending on the volume of target tissue being treated, and/or the maximum allowed temperature selected for the probe tip. The power supply allows the user to select the voltage level according to the specific requirements of a particular procedure, e.g., spinal surgery, arthroscopic surgery, dermatological procedure, ophthalmic procedures, open surgery, or other endoscopic surgery procedure.
As shown in
Power is supplied to RF oscillator 70 by a switching power supply 72 coupled between the power line and the RF oscillator rather than a conventional transformer. The switching power supply 72 allows power supply 28 to achieve high peak power output without the large size and weight of a bulky transformer. The architecture of the switching power supply also has been designed to reduce electromagnetic noise such that U.S. and foreign EMI requirements are met. This architecture comprises a zero voltage switching or crossing, which causes the transistors to turn ON and OFF when the voltage is zero. Therefore, the electromagnetic noise produced by the transistors switching is vastly reduced. In an exemplary embodiment, the switching power supply 72 operates at about 100 kHz.
A controller 74 coupled to the operator controls 73 (i.e., foot pedals and voltage selector) and display 76, is connected to a control input of the switching power supply 72 for adjusting the generator output power by supply voltage variation. The controller 74 may be a microprocessor or an integrated circuit. The power supply may also include one or more current sensors 75 for detecting the output current. The power supply is preferably housed within a metal casing which provides a durable enclosure for the electrical components therein. In addition, the metal casing reduces the electromagnetic noise generated within the power supply because the grounded metal casing functions as a “Faraday shield,” thereby shielding the environment from internal sources of electromagnetic noise.
The power supply generally comprises a main or mother board containing generic electrical components required for many different surgical procedure (e.g., arthroscopy, urology, general surgery, dermatology, neurosurgery, etc.), and a daughter board containing application specific current-limiting circuitry (e.g., inductors, resistors, capacitors and the like). The daughter board is coupled to the mother board by a detachable multi-pin connector to allow convenient conversion of the power supply to, e.g., applications requiring a different current limiting circuit design. For arthroscopy, for example, the daughter board preferably comprises a plurality of inductors of about 200 to 400 microhenries, usually about 300 microhenries, for each of the channels supplying current to the active electrodes 102 (see FIG. 4).
Alternatively, in one embodiment, current limiting inductors are placed in series with each independent active electrode, where the inductance of the inductor is in the range of 10 uH to 50,000 uH, depending on the electrical properties of the target tissue, the desired tissue heating rate and the operating frequency. Alternatively, capacitor-inductor (LC) circuit structures may be employed, as described previously in co-pending PCT application Ser. No. PCT/US94/05168, the complete disclosure of which is incorporated herein by reference. Additionally, current limiting resistors may be selected. Preferably, these resistors will have a large positive temperature coefficient of resistance so that, as the current level begins to rise for any individual active electrode in contact with a low resistance medium (e.g., saline irrigant or conductive gel), the resistance of the current limiting resistor increases significantly, thereby minimizing the power delivery from said active electrode into the low resistance medium (e.g., saline irrigant or conductive gel). Power output signal may also be coupled to a plurality of current limiting elements 96, which are preferably located on the daughter board since the current limiting elements may vary depending on the application. A more complete description of a representative power supply can be found in commonly assigned U.S. patent application Ser. No. 09/058,571, previously incorporated herein by reference.
Handle 204 typically comprises a plastic material that is easily molded into a suitable shape for handling by the surgeon. Handle 204 defines an inner cavity (not shown) that houses the electrical connections 250 (FIG. 6), and provides a suitable interface for connection to an electrical connecting cable distal portion 22 (see
As shown in
In the embodiment shown in FIGS 4 to 6, probe 20 includes a return electrode 112 for completing the current path between active electrodes 104 and a high frequency power supply 28 (see FIG. 1). As shown, return electrode 112 preferably comprises an exposed portion of shaft 100 shaped as an annular conductive band near the distal end of shaft 100 slightly proximal to tissue treatment surface 212 of electrode support member 102, typically about 0.5 mm to 10 mm and more preferably about 1 mm to 10 mm. Return electrode 112 or shaft 100 is coupled to a connector 258 that extends to the proximal end of probe 10/20, where it is suitably connected to power supply 28 (FIG. 1).
As shown in
In alternative embodiments, the fluid path may be formed in probe 90 by, for example, an inner lumen or an annular gap between the return electrode and a tubular support member within shaft 100 (see FIGS. 8A and 8B). This annular gap may be formed near the perimeter of the shaft 100 such that the electrically conductive fluid tends to flow radially inward towards the target site, or it may be formed towards the center of shaft 100 so that the fluid flows radially outward. In both of these embodiments, a fluid source (e.g., a bag of fluid elevated above the surgical site or having a pumping device), is coupled to probe 90 via a fluid supply tube (not shown) that may or may not have a controllable valve. A more complete description of an electrosurgical probe incorporating one or more fluid lumen(s) can be found in U.S. Pat. No. 5,697,281, the complete disclosure of which has previously been incorporated herein by reference.
Referring to
In the embodiment of
Of course, it will be recognized that the distal tip of an electrosurgical probe of the invention, e.g. probe 10/20/90, may have a variety of different configurations. For example, the probe may include a plurality of openings 209 around the outer perimeter of tissue treatment surface 212 (see FIG. 7B). In this embodiment, the active electrodes 104 extend distally from the center of tissue treatment surfaces 212 such that they are located radially inward from opening 209. The openings are suitably coupled to fluid tube 233 for delivering electrically conductive fluid to the target site, and suction tube 211 for aspirating the fluid after it has completed the conductive path between the return electrode 112 and the active electrodes 104.
According to the present invention, the probe 20 further includes an identification element that is characteristic of the particular electrode assembly so that the same power supply 28 can be used for different electrosurgical operations. In one embodiment, for example, the probe (e.g., 20) includes a voltage reduction element or a voltage reduction circuit for reducing the voltage applied between the active electrodes 104 and the return electrode 112. The voltage reduction element serves to reduce the voltage applied by the power supply so that the voltage between the active electrodes and the return electrodes is low enough to avoid excessive power dissipation into the electrically conducting medium and/or ablation of the soft tissue at the target site. In some embodiments, the voltage reduction element allows the power supply 28 to apply two different voltages simultaneously to two different electrodes (see FIG. 15D). In other embodiments, the voltage reduction element primarily allows the electrosurgical probe to be compatible with various electrosurgical generators supplied by ArthroCare Corporation (Sunnyvale, Calif.) that are adapted to apply higher voltages for ablation or vaporization of tissue. For thermal heating or coagulation of tissue, for example, the voltage reduction element will serve to reduce a voltage of about 100 volts rms to 170 volts rms (which is a setting of 1 or 2 on the ArthroCare Model 970 and 980 (i.e., 2000) Generators) to about 45 volts rms to 60 volts rms, which is a suitable voltage for coagulation of tissue without ablation (e.g., molecular dissociation) of the tissue.
Of course, for some procedures, the probe will typically not require a voltage reduction element. Alteratively, the probe may include a voltage increasing element or circuit, if desired. Alternatively or additionally, the cable 34 and/or cable distal end 22 that couples the power supply 28 to the probe may be used as a voltage reduction element. The cable has an inherent capacitance that can be used to reduce the power supply voltage if the cable is placed into the electrical circuit between the power supply, the active electrodes and the return electrode. In this embodiment, the cable distal end 22 may be used alone, or in combination with one of the voltage reduction elements discussed above, e.g., a capacitor. Further, it should be noted that the present invention can be used with a power supply that is adapted to apply a voltage within the selected range for treatment of tissue. In this embodiment, a voltage reduction element or circuitry may not be desired.
In a preferred construction technique, active electrodes 104 extend through pre-formed openings in the support matrix 102′ so that they protrude above tissue treatment surface 212 by the desired distance. The electrodes are then bonded to the tissue treatment surface 212 of support matrix 102′, typically by an inorganic sealing material 80. Sealing material 80 is selected to provide effective electrical insulation, and good adhesion to both support matrix 102′ and the platinum or titanium active electrodes. Sealing material 80 additionally should have a compatible thermal expansion coefficient and a melting point well below that of platinum or titanium and alumina or zirconia, typically being a glass or glass ceramic.
In the embodiment shown in
Return electrode 112 is disposed within an electrically insulative jacket 118, which is typically formed as one or more electrically insulative sheaths or coatings, such as polytetrafluoroethylene, polyimide, and the like. The provision of the electrically insulative jacket 118 over return electrode 112 prevents direct electrical contact between return electrode 112 and any adjacent body structure. Such direct electrical contact between a body structure (e.g., tendon) and an exposed return electrode 112 could result in unwanted heating and necrosis of the structure at the point of contact.
As shown in
In some embodiments, the probe 20/90 will also include one or more aspiration electrode(s) coupled to the aspiration lumen for inhibiting clogging during aspiration of tissue fragments from the surgical site. As shown in
In some embodiments, loop electrodes 140 are electrically isolated from the other active electrodes 104. In other embodiments, the loop electrodes 140 and active electrodes 104 may be electrically connected to each other such that both are activated together. Loop electrodes 140 may or may not be electrically isolated from each other. Loop electrodes 140 will usually extend only about 0.05 mm to 4 mm, preferably about 0.1 mm to 1 mm from the tissue treatment surface of electrode support member 102.
Referring now to
Referring to
Referring to
Referring now to
In alternative embodiments, the electrosurgical system used in conjunction with probe 350 may include a dispersive return electrode 450 (see
Of course, it will be recognized that a variety of other embodiments may be used to accomplish similar functions as the embodiments described above. For example, electrosurgical probe 350 may include a plurality of helical bands formed around shaft 352, with one or more of the helical bands having an electrode coupled to the portion of the band such that one or more electrodes are formed on shaft 352 spaced axially from each other.
The probe 350 in
In the representative embodiment, the voltage reduction element comprises a pair of capacitors forming a bridge divider(not shown) coupled to the power supply and coagulation electrode 380. The capacitors usually have a capacitance of about 200 pF to 500 pF (at 500 volts) and preferably about 300 pF to 350 pF (at 500 volts). Of course, the capacitors may be located in other places within the system, such as in, or distributed along the length of, the cable, the generator, the connector, etc. In addition, it will be recognized that other voltage reduction elements, such as diodes, transistors, inductors, resistors, capacitors or combinations thereof, may be used in conjunction with the present invention. For example, the probe 350 may include a coded resistor (not shown) that is constructed to lower the voltage applied between the return and coagulation electrodes 360, 380, respectively. In addition, electrical circuits may be employed for this purpose.
Of course, for some procedures, the probe will typically not require a voltage reduction element. Alternatively, the probe may include a voltage increasing element or circuit, if desired. Alternatively or additionally, cable 22/34 that couples power supply 28 to the probe 90 may be used as a voltage reduction element. The cable has an inherent capacitance that can be used to reduce the power supply voltage if the cable is placed into the electrical circuit between the power supply, the active electrodes and the return electrode. In this embodiment, cable 22/34 may be used alone, or in combination with one of the voltage reduction elements discussed above, e.g., a capacitor. Further, it should be noted that the present invention can be used with a power supply that is adapted to apply two different voltages within the selected range for treatment of tissue. In this embodiment, a voltage reduction element or circuitry may not be desired.
In one specific embodiment, the probe 350 is manufactured by first inserting an electrode wire (active electrode 362) through a ceramic tube (insulating member 356) such that a distal portion of the wire extends through the distal portion of the tube, and bonding the wire to the tube, typically with an appropriate epoxy. A stainless steel tube (return electrode 360) is then placed over the proximal portion of the ceramic tube, and a wire (e.g., nickel wire) is bonded, typically by spot welding, to the inside surface of the stainless steel tube. The stainless steel tube is coupled to the ceramic tube by epoxy, and the device is cured in an oven or other suitable heat source. A second ceramic tube (insulating member 382) is then placed inside of the proximal portion of the stainless steel tube, and bonded in a similar manner. The shaft 358 is then bonded to the proximal portion of the second ceramic tube, and an insulating sleeve (e.g., polymide) is wrapped around shaft 358 such that only a distal portion of the shaft is exposed (i.e., coagulation electrode 380). The nickel wire connection will extend through the center of shaft 358 to connect return electrode 360 to the power supply. The active electrode 362 may form a distal portion of shaft 358, or it may also have a connector extending through shaft 358 to the power supply.
In use, the physician positions active electrode 362 adjacent to the tissue surface to be treated (i.e., a spinal disc). The power supply is activated to provide an ablation voltage between active and return electrodes 362, 360, respectively, and a coagulation or thermal heating voltage between coagulation and return electrodes 380, 360, respectively. An electrically conductive fluid can then be provided around active electrode 362, and in the junction between the active and return electrodes 360, 362 to provide a current flow path therebetween. This may be accomplished in a variety of manners, as discussed above. The active electrode 362 is then advanced through the space left by the ablated tissue to form a channel in the disc. During ablation, the electric current between the coagulation and return electrode is typically insufficient to cause any damage to the surface of the tissue as these electrodes pass through the tissue surface into the channel created by active electrode 362. Once the physician has formed the channel to the appropriate depth, he or she will cease advancement of the active electrode, and will either hold the instrument in place for approximately 5 seconds to 30 seconds, or can immediately remove the distal tip of the instrument from the channel (see detailed discussion of this below). In either event, when the active electrode is no longer advancing, it will eventually stop ablating tissue.
Prior to entering the channel formed by the active electrode 362, an open circuit exists between return and coagulation electrodes 360, 380. Once coagulation electrode 380 enters this channel, electric current will flow from coagulation electrode 380, through the tissue surrounding the channel, to return electrode 360. This electric current will heat the tissue immediately surrounding the channel to coagulate any severed vessels at the surface of the channel. If the physician desires, the instrument may be held within the channel for a period of time to create a lesion around the channel, as discussed in more detail below.
In one configuration, the dispersive return pad 450 is adapted for coupling to an external surface of the patient in a region substantially close to the target region. For example, during the treatment of tissue in the head and neck, the dispersive return pad is designed and constructed for placement in or around the patient's shoulder, upper back or upper chest region. This design limits the current path through the patient's body to the head and neck area, which minimizes the damage that may be generated by unwanted current paths in the patient'body, particularly by limiting current flow through the patient's heart. The return pad is also designed to minimize the current densities at the pad, to thereby minimize patient skin burns in the region where the pad is attached.
Referring to
Catheter body 462 may include reinforcing fibers or braids (not shown) in the walls of at least the distal ablation region 464 of body 462 to provide responsive torque control for rotation of active electrodes during tissue engagement. This rigid portion of the catheter body 462 preferably extends only about 7 mm to 10 mm while the remainder of the catheter body 462 is flexible to provide good trackability during advancement and positioning of the electrodes adjacent target tissue.
In some embodiments, conductive fluid 50 is provided to tissue ablation region 464 of catheter 460 via a lumen (not shown in
System 400 can further include an aspiration or vacuum system (not shown) to aspirate liquids and gases from the target site. The aspiration system will usually comprise a source of vacuum coupled to fitment 614 by a aspiration connector 605.
The present invention is particularly useful in microendoscopic discectomy procedures, e.g., for decompressing a nerve root with a lumbar discectomy. As shown in
As shown in
According to another aspect of the present invention, an electrosurgical probe or catheter 284 as described above is introduced into the operating corridor within the retractor 278 to remove the soft tissue, muscle and other obstructions from this corridor so that the surgeon can easily access and visualization the lamina 274. Once the surgeon has introduced the probe 284, electrically conductive fluid 285 can be delivered through tube 233 and opening 237 to the tissue (see FIG. 4). The fluid flows past the return electrode 112 to the active electrodes 104 at the distal end of the shaft. The rate of fluid flow is controlled with valve 17 (
The high frequency voltage is sufficient to convert the electrically conductive fluid (not shown) between the target tissue and active electrode(s) 104 into an ionized vapor layer or plasma (not shown). As a result of the applied voltage difference between active electrode(s) 104 and the target tissue (i.e., the voltage gradient across the plasma layer), charged particles in the plasma (viz, electrons) are accelerated towards the tissue. At sufficiently high voltage differences, these charged particles gain sufficient energy to cause dissociation of the molecular bonds within tissue structures. This molecular dissociation is accomplished by the volumetric removal (i.e., ablative sublimation) of tissue and the production of low molecular weight gases, such as oxygen, nitrogen, carbon dioxide, hydrogen and methane. The short range of the accelerated charged particles within the tissue confines the molecular dissociation process to the surface layer to minimize damage and necrosis to the underlying tissue.
During the process, the gases will be aspirated through opening 209 and suction tube 211 to a vacuum source. In addition, excess electrically conductive fluid, and other fluids (e.g., blood) will be aspirated from the operating corridor to facilitate the surgeon's view. During ablation of the tissue, the residual heat generated by the current flux lines (typically less than 150° C.), will usually be sufficient to coagulate any severed blood vessels at the site. If not, the surgeon may switch the power supply 28 into the coagulation mode by lowering the voltage to a level below the threshold for fluid vaporization, as discussed above. This simultaneous hemostasis results in less bleeding and facilitates the surgeon's ability to perform the procedure.
Another advantage of the present invention is the ability to precisely ablate soft tissue without causing necrosis or thermal damage to the underlying and surrounding tissues, nerves or bone. In addition, the voltage can be controlled so that the energy directed to the target site is insufficient to ablate the lamina 274 so that the surgeon can literally clean the tissue off the lamina 274, without ablating or otherwise effecting significant damage to the lamina.
Referring now to
In another embodiment, the present invention involves a channeling technique in which small holes or channels are formed within the disc 290, and thermal energy is applied to the tissue surface immediately surrounding these holes or channels to cause thermal damage to the tissue surface, thereby stiffening and debulking the surrounding tissue structure of the disc. Applicant has discovered that such stiffening of the tissue structure in the disc helps to reduce the pressure applied against the spinal nerves by the disc, thereby relieving back and neck pain.
As shown in
Depending on the procedure, the surgeon may translate or otherwise move the electrodes relative to the target disc tissue to form holes, channels, stripes, divots, craters or the like within the disc. In addition, the surgeon may purposely create some thermal damage within these holes, or channels to form scar tissue that will stiffen and debulk the disc. In one embodiment, the physician axially translates the electrode assembly 351 into the disc tissue as the tissue is volumetrically removed to form one or more holes 702 therein (see also FIG. 22). The holes 702 will typically have a diameter of less than 2 mm, preferably less than 1 mm. In another embodiment (not shown), the physician translates the active electrode across the outer surface of the disc to form one or more channels or troughs. Applicant has found that the present invention can quickly and clearly create such holes, divots or channels in tissue with the cold ablation technology described herein. A more complete description of methods for forming holes or channels in tissue can be found in U.S. Pat. No. 5,683,366, the complete disclosure of which is incorporated herein by reference for all purposes.
During the formation of each hole 702, the conductive fluid between active and return electrodes 362, 360 will generally minimize current flow into the surrounding tissue, thereby minimizing thermal damage to the tissue. Therefore, severed blood vessels on the surface 705 of the hole 702 may not be coagulated as the electrodes 362 advance through the tissue. In addition, in some procedures, it may be desired to thermally damage the surface 705 of the holes 702 to stiffen the tissue. For these reasons, it may be desired in some procedures to increase the thermal damage caused to the tissue surrounding hole 702. In the embodiment shown in
In other embodiments, the physician switches the electrosurgical system from the ablation mode to the subablation or thermal heating mode after the hole 702 has been formed. This is typically accomplished by pressing a switch or foot pedal to reduce the voltage applied to a level below the threshold required for ablation for the particular electrode configuration and the conductive fluid being used in the procedure (as described above). In the subablation mode, the physician will then remove the distal end of the probe 350 from the hole 702. As the probe is withdrawn, high frequency current flows from the active electrodes 362 through the surrounding tissue to the return electrode 360. This current flow heats the tissue and coagulates severed blood vessels at surface 705.
In another embodiment, the electrosurgical probe of the present invention can be used to ablate and/or contract soft tissue within the disc 290 to allow the annulus fibrosus 292 to repair itself to prevent reoccurrence of this procedure. For tissue contraction, a sufficient voltage difference is applied between the active electrodes 104 and the return electrode 112 to elevate the tissue temperature from normal body temperature (e.g., 37° C.) to temperatures in the range of 45° C. to 90° C., preferably in the range from 60° C. to 70° C. This temperature elevation causes contraction of the collagen connective fibers within the disc tissue so that the nucleus pulposus withdraws into the annulus fibrosus 292.
In one method of tissue contraction according to the present invention, an electrically conductive fluid is delivered to the target site as described above, and heated to a sufficient temperature to induce contraction or shrinkage of the collagen fibers in the target tissue. The electrically conductive fluid is heated to a temperature sufficient to substantially irreversibly contract the collagen fibers, which generally requires a tissue temperature in the range of about 45° C. to 90° C., usually about 60° C. to 70° C. The fluid is heated by applying high frequency electrical energy to the active electrode(s) in contact with the electrically conductive fluid. The current emanating from the active electrode(s) 104 heats the fluid and generates a jet or plume of heated fluid, which is directed towards the target tissue. The heated fluid elevates the temperature of the collagen sufficiently to cause hydrothermal shrinkage of the collagen fibers. The return electrode 112 draws the electric current away from the tissue site to limit the depth of penetration of the current into the tissue, thereby inhibiting molecular dissociation and breakdown of the collagen tissue and minimizing or completely avoiding damage to surrounding and underlying tissue structures beyond the target tissue site. In an exemplary embodiment, the active electrode(s) 104 are held away from the tissue a sufficient distance such that the RF current does not pass into the tissue at all, but rather passes through the electrically conductive fluid back to the return electrode. In this embodiment, the primary mechanism for imparting energy to the tissue is the heated fluid, rather than the electric current.
In an alternative embodiment, the active electrode(s) 104 are brought into contact with, or close proximity to, the target tissue so that the electric current passes directly into the tissue to a selected depth. In this embodiment, the return electrode draws the electric current away from the tissue site to limit its depth of penetration into the tissue. Applicant has discovered that the depth of current penetration also can be varied with the electrosurgical system of the present invention by changing the frequency of the voltage applied to the active electrode and the return electrode. This is because the electrical impedance of tissue is known to decrease with increasing frequency due to the electrical properties of cell membranes which surround electrically conductive cellular fluid. At lower frequencies (e.g., less than 350 kHz), the higher tissue impedance, the presence of the return electrode and the active electrode configuration of the present invention (discussed in detail below) cause the current flux lines to penetrate less deeply resulting in a smaller depth of tissue heating. In an exemplary embodiment, an operating frequency of about 100 kHz to 200 kHz is applied to the active electrode(s) to obtain shallow depths of collagen shrinkage (e.g., usually less than 1.5 mm and preferably less than 0.5 mm).
In another aspect of the invention, the size (e.g., diameter or principle dimension) of the active electrodes employed for treating the tissue are selected according to the intended depth of tissue treatment. As described previously in co-pending patent application PCT International Application, U.S. National Phase Ser. No. PCT/US94/05168, the depth of current penetration into tissue increases with increasing dimensions of an individual active electrode (assuming other factors remain constant, such as the frequency of the electric current, the return electrode configuration, etc.). The depth of current penetration (which refers to the depth at which the current density is sufficient to effect a change in the tissue, such as collagen shrinkage, irreversible necrosis, etc.) is on the order of the active electrode diameter for the bipolar configuration of the present invention and operating at a frequency of about 100 kHz to about 200 kHz. Accordingly, for application requiring a smaller depth of current penetration, one or more active electrodes of smaller dimensions would be selected. Conversely, for application requiring a greater depth of current penetration, one or more active electrodes of larger dimensions would be selected.
As shown in
As shown in
The “S-curve” configuration of shaft 902 shown in
The “S-curve” design of shaft distal end portion 902a allows the distal tip (e.g., electrode head 911) to be advanced and retracted through the distal opening of needle 928 while avoiding contact between the distal tip and the edges of the distal opening of needle 928. (If, for example, shaft distal end portion 902a included only a single curve the distal tip would ordinarily come into contact with needle distal end 928a as shaft 902 is retracted into the lumen of needle 928.) In preferred embodiments, the length L2 of distal portion 909 and the angle ∀ between distal portion 909 and needle inner surface 932928, when shaft distal end portion 902a is compressed within needle 928, are selected such that the distal tip is substantially in the center of the lumen of needle 928, as shown in FIG. 27B. Thus, as the length L2 increases, the angle ∀ will decrease, and vice versa. The exact values of length L2 and angle ∀ will depend on the inner diameter, D of needle 928, the inner diameter, d of shaft distal end portion 902a, and the size of the shaft distal tip.
The presence of first and second curves, 924, 926 provides a pre-defined bias in shaft 902. In addition, in one embodiment shaft distal end portion 902a is designed such that at least one of first and second curves 924, 926 are compressed to some extent as shaft distal end portion 902a is retracted into the lumen of needle 928. Accordingly, the angle of at least one of curves 924, 926 may be changed when distal end portion 902a is advanced out through the distal opening of introducer needle 928, as compared with the corresponding angle when shaft distal end portion is completely retracted within introducer needle 928. For example,
The principle described above with reference to shaft 902 and introducer needle 928 may equally apply to a range of other medical devices. That is to say, the “S-curve” configuration of the invention may be included as a feature of any medical system or apparatus in which a medical instrument may be axially translated or passed within an introducer device. In particular, the principle of the “S-curve” configuration of the invention may be applied to any apparatus wherein it is desired that the distal end of the medical instrument does not contact or impinge upon the introducer device as the medical instrument is advanced from or retracted into the introducer device. The introducer device may be any apparatus through which a medical instrument is passed. Such medical systems may include, for example, a catheter, a cannula, an endoscope, and the like.
When shaft 902 is advanced distally through the needle lumen to a point where second curve 926 is located distal to needle distal end 928a, the shaft distal tip is deflected from the longitudinal axis of needle 928. The amount of this deflection is determined by the relative size of angles ∃′ and ∀′, and the relative lengths of L1 and L2. The amount of this deflection will in turn determine the size of a channel or lesion (depending on the application) formed in a tissue treated by electrode head 911 when shaft 902 is rotated circumferentially with respect to the longitudinal axis of probe 900.
As a result of the pre-defined bias in shaft 902, shaft distal end portion 902a will contact a larger volume of tissue than a linear shaft having the same dimensions. In addition, in one embodiment the pre-defined bias of shaft 902 allows the physician to guide or steer the distal tip of shaft 902 by a combination of axial movement of needle distal end 928a and the inherent curvature at shaft distal end portion 902a of probe 900.
Shaft 902 preferably has a length in the range of from about 4 to 30 cm. In one aspect of the invention, probe 900 is manufactured in a range of sizes having different lengths and/or diameters of shaft 902. A shaft of appropriate size can then be selected by the surgeon according to the body structure or tissue to be treated and the age or size of the patient. In this way, patients varying in size from small children to large adults can be accommodated. Similarly, for a patient of a given size, a shaft of appropriate size can be selected by the surgeon depending on the organ or tissue to be treated, for example, whether an intervertebral disc to be treated is in the lumbar spine or the cervical spine. For example, a shaft suitable for treatment of a disc of the cervical spine may be substantially smaller than a shaft for treatment of a lumbar disc. For treatment of a lumbar disc in an adult, shaft 902 is preferably in the range of from about 15 to 25 cm. For treatment of a cervical disc, shaft 902 is preferably in the range of from about 4 to about 15 cm.
The diameter of shaft 902 is preferably in the range of from about 0.5 to about 2.5 mm, and more preferably from about 1 to 1.5 mm. First curve 924 is characterized by a length L1, while second curve 926 is characterized by a length L2 (FIG. 27B). Inter-curve portion 925 is characterized by a length L3, while shaft 902 extends distally from first curve 924 a length L4. In one embodiment, L2 is greater than L1. Length L1 may be in the range of from about 0.5 to about 5 mm, while L2 may be in the range of from about 1 to about 10 mm. Preferably, L3 and L4 are each in the range of from about 1 to 6 mm.
Step 1002 involves covering or encasing the filament with a first insulating sleeve of an electrically insulating material such as a synthetic polymer or plastic, e.g., a polyimide. Preferably, the first insulating sleeve extends the entire length of the shaft. Step 1004 involves positioning a collar of an electrically insulating material on the distal end of the first insulating sleeve, wherein the collar is located adjacent to the electrode head. The collar is preferably a material such as a glass, a ceramic, or silicone. Step 1006 involves placing a cylindrical return electrode over the first insulating sleeve. Preferably, the return electrode is positioned such that its distal end is contiguous with the proximal end of the collar, and the return electrode preferably extends proximally for the entire length of the shaft. The return electrode may be constructed from stainless steel of other non-corrosive, electrically conductive metal.
According to one embodiment, a metal cylindrical return electrode is prebent to include a curve within its distal region (i.e. the return electrode component is bent prior to assembly onto the shaft). As a result, the shaft assumes a first curve upon placing the return electrode over the first insulating sleeve, i.e. the first curve in the shaft results from the bend in the return electrode. Step 1008 involves covering a portion of the return electrode with a second insulating layer or sleeve such that a band of the return electrode is exposed distal to the distal end of the second insulating sleeve. In one embodiment, the second insulating sleeve comprises a heat-shrink plastic material which is heated prior to positioning the second insulating sleeve over the return electrode. According to one embodiment, the second insulating sleeve is initially placed over the entire length of the shaft, and thereafter the distal end of the second insulating sleeve is cut back to expose an appropriate length of the return electrode. Step 1010 involves encasing a proximal portion of the second insulating sleeve within a shield of electrically conductive material, such as a cylinder of stainless steel or other metal, as previously described herein.
Many patients suffer from discogenic pain resulting, for example, from conditions of the type depicted in
Shaft 902 includes an active electrode 910, as described hereinabove. Shaft 902 features curvature at distal end 902a/902′a, for example, as described with reference to
It is to be understood that according to certain embodiments of the invention, the curvature of shaft 902 is the same, or substantially the same, both prior to it being used in a surgical procedure and while it is performing ablation during a procedure, e.g., within an intervertebral disc. (One apparent exception to this statement, relates to the stage in a procedure wherein shaft 902 may be transiently “molded” into a somewhat more linear configuration by the constraints of introducer inner wall 932 during housing, or passing, or shaft 902 within introducer 928.) In contrast, certain prior art devices, and embodiments of the invention to be described hereinbelow (e.g., with reference to
While shaft distal end 902a is at or adjacent to a target site within the nucleus pulposus, probe 900 may be used to ablate tissue by application of a first high frequency voltage between active electrode 910 and return electrode 918 (e.g., FIG. 26B), wherein the volume of the nucleus pulposus is decreased, the pressure exerted by the nucleus pulposus on the annulus fibrosus is decreased, and at least one nerve or nerve root is decompressed. Accordingly, discogenic pain experienced by the patient may be alleviated. Preferably, application of the first high frequency voltage results in formation of a plasma in the vicinity of active electrode 910, and the plasma causes ablation by breaking down high molecular weight disc tissue components (e.g., proteins) into low molecular weight gaseous materials. Such low molecular weight gaseous materials may be at least partially vented or exhausted from the disc, e.g., by piston action, upon removal of the shaft 902 and introducer 928 from the disc and the clearance between the introducer 928 and the shaft 902. In addition, by-products of tissue ablation may be removed by an aspiration device (not shown in FIG. 37), as is well known in the art. In this manner, the volume and/or mass of the nucleus pulposus may be decreased.
In order to initiate and/or maintain a plasma in the vicinity of active electrode 910, a quantity of an electrically conductive fluid may be applied to shaft 902 and/or the tissue to ablated. The electrically conductive fluid may be applied to shaft 902 and/or to the tissue to be ablated, either before or during application of the first high frequency voltage. Examples of electrically conductive fluids are saline (e.g., isotonic saline), and an electrically conductive gel. An electrically conductive fluid may be applied to the tissue to be ablated before or during ablation. A fluid delivery unit or device may be a component of the electrosurgical probe itself, or may comprise a separate device, e.g., ancillary device 940 (FIG. 41). Alternatively, many body fluids and/or tissues (e.g., the nucleus pulposus, blood) at the site to be ablated are electrically conductive and can participate in initiation or maintenance of a plasma in the vicinity of the active electrode.
In one embodiment, after ablation of nucleus pulposus tissue by the application of the first high frequency voltage and formation of a cavity or channel within the nucleus pulposus, a second high frequency voltage may be applied between active electrode 910 and return electrode 918, wherein application of the second high frequency voltage causes coagulation of nucleus pulposus tissue adjacent to the cavity or channel. Such coagulation of nucleus pulposus tissue may lead to increased stiffness, strength, and/or rigidity within certain regions of the nucleus pulposus, concomitant with an alleviation of discogenic pain. Furthermore, coagulation of tissues may lead to necrotic tissue which is subsequently broken down as part of a natural bodily process and expelled from the body, thereby resulting in de-bulking of the disc. Although
Optional step 1202 involves introducing an electrically conductive fluid, such as saline, into the disc. In one embodiment, in lieu of step 1202, the ablation procedure may rely on the electrical conductivity of the nucleus pulposus itself. Step 1204 involves inserting the shaft of the electrosurgical probe into the disc, e.g., via the introducer needle, wherein the distal end portion of the shaft bears an active electrode and a return electrode. In one embodiment, the shaft includes an outer shield, first and second curves at the distal end portion of the shaft, and an electrode head having an apical spike, generally as described with reference to
Step 1206 involves ablating at least a portion of disc tissue by application of a first high frequency voltage between the active electrode and the return electrode. In particular, ablation of nucleus pulposus tissue according to methods of the invention serves to decrease the volume of the nucleus pulposus, thereby relieving pressure exerted on the annulus fibrosus, with concomitant decompression of a previously compressed nerve root, and alleviation of discogenic pain.
In one embodiment, the introducer needle is advanced towards the intervertebral disc until it penetrates the annulus fibrosus and enters the nucleus pulposus. The shaft distal end in introduced into the nucleus pulposus, and a portion of the nucleus pulposus is ablated. These and other stages of the procedure may be performed under fluoroscopy to allow visualization of the relative location of the introducer needle and shaft relative to the nucleus pulposus of the disc. Additionally or alternatively, the surgeon may introduce the introducer needle into the nucleus pulposus from a first side of the disc, then advance the shaft distal end through the nucleus pulposus until resistance to axial translation of the electrosurgical probe is encountered by the surgeon. Such resistance may be interpreted by the surgeon as the shaft distal end having contacted the annulus fibrosus at the opposite side of the disc. Then, by use of depth markings one the shaft (FIG. 32A), the surgeon can retract the shaft a defined distance in order to position the shaft distal end at a desired location relative to the nucleus pulposus. Once the shaft distal end is suitably positioned, high frequency voltage may be applied to the probe via the power supply unit.
After step 1206, optional step 1208 involves coagulating at least a portion of the disc tissue. In one embodiment, step 1206 results in the formulation of a channel or cavity within the nucleus pulposus. Thereafter, tissue at the surface of the channel may be coagulated during step 1208. Coagulation of disc tissue may be performed by application of a second high frequency voltage, as described hereinabove. After step 1206 or step 1208, the shaft may be moved (step 1210) such that the shaft distal end contacts fresh tissue of the nucleus pulposus. The shaft may be axially translated (i.e. moved in the direction of its longitudinal axis), may be rotated about its longitudinal axis, or may be moved by a combination of axial and rotational movement. In the latter case, a substantially spiral path is defined by the shaft distal end. After step 1210, steps 1206 and 1208 may be repeated with respect to the fresh tissue of the nucleus pulposus contacted by the shaft distal end. Alternatively, after step 1206 or step 1208, the shaft may be withdrawn from the disc (step 1212). Step 1214 involves withdrawing the introducer needle from the disc. In one embodiment, the shaft and the needle may be withdrawn from the disc concurrently. Withdrawal of the shaft from the disc may facilitate exhaustion of ablation by-products from the disc. Such ablation by-products include low molecular weight gaseous compounds derived from molecular dissociation of disc tissue components, as described hereinabove. The above method may be used to treat any disc disorder in which Coblation® and or coagulation of disc tissue is indicated, including contained herniations. In one embodiment, an introducer needle may be introduced generally as described for step 1200, and a fluoroscopic fluid may be introduced through the lumen of the introducer needle for the purpose of visualizing and diagnosing a disc abnormality or disorder. Thereafter, depending on the diagnosis, a treatment procedure may be performed, e.g., according to steps 1202 through 1214, using the same introducer needle as access. In one embodiment, a distal portion, or the entire length, of the introducer needle may have an insulating coating on its external surface. Such an insulating coating on the introducer needle may prevent interference between the electrically conductive introducer needle and electrode(s) on the probe.
The size of the cavity or channel formed in a tissue by a single straight pass of the shaft through the tissue to be ablated is a function of the diameter of the shaft (e.g., the diameter of the shaft distal end and active electrode) and the amount of axial translation of the shaft. (By a “single straight pass” of the shaft is meant one axial translation of the shaft in a distal direction through the tissue, in the absence of rotation of the shaft about the longitudinal axis of the shaft, with the power from the power supply turned on.) In the case of a curved shaft, according to various embodiments of the instant invention, a larger channel can be formed by rotating the shaft as it is advanced through the tissue. The size of a channel formed in a tissue by a single rotational pass of the shaft through the tissue to be ablated is a function of the deflection of the shaft, and the amount of rotation of the shaft about its longitudinal axis, as well as the diameter of the shaft (e.g., the diameter of the shaft distal end and active electrode) and the amount of axial translation of the shaft. (By a “single rotational pass” of the shaft is meant one axial translation of the shaft in a distal direction through the tissue, in the presence of rotation of the shaft about the longitudinal axis of the shaft, with the power from the power supply turned on.) To the large extent, the diameter of a channel formed during a rotational pass of the shaft through tissue can be controlled by the amount of rotation of the shaft, wherein the “amount of rotation” encompasses both the rate of rotation (e.g., the angular velocity of the shaft), and the number of degrees through which the shaft is rotated (e.g. the number of turns) per unit length of axial movement. Typically, according to the invention, the amount of axial translation per pass (for either a straight pass or a rotational pass) is not limited by the length of the shaft. Instead, the amount of axial translation per single pass is preferably determined by the size of the tissue to be ablated. Depending on the size of the disc or other tissue to be treated, and the nature of the treatment, etc., a channel formed by a probe of the instant invention may preferably have a length in the range of from about 2 mm to about 50 mm, and a diameter in the range of from about 0.5 mm to about 7.5 mm. In comparison, a channel formed by a shaft of the instant invention during a single rotational pass may preferably have a diameter in the range of from about 1.5 mm to about 25 mm.
A channel formed by a shaft of the instant invention during a single straight pass may preferably have a volume in the range of from about 1 mm3, or less, to about 2,500 mm3. More preferably, a channel formed by a straight pass of a shaft of the instant invention has a volume in the range of from about 10 mm3 to about 2,500 mm3, and more preferably in the range of from about 50 mm3 to about 2,500 mm3. In comparison, a channel formed by a shaft of the instant invention during a single rotational pass typically has a volume from about twice to about 15 times the volume of a channel of the same length formed during single rotational pass, i.e., in the range of from about 2 mm3 to about 4,000 mm3, more preferably in the range of from about 50 mm3 to about 2,000 mm3. While not being bound by theory, the reduction in volume of a disc having one or more channels therein is a function of the total volume of the one or more channels.
Guiding the shaft distal end to the defined target site may be performed by axial and/or rotational movement of a curved shaft, as described hereinabove. Or the shaft may be steerable, for example, by means of a guide wire, as is well known in the art. Guiding the shaft distal end may be performed during visualization of the location of the shaft relative to the disc, wherein the visualization may be performed endoscopically or via fluoroscopy. Endoscopic examination may employ a fiber optic cable (not shown). The fiber optic cable may be integral with the electrosurgical probe, or be part of a separate instrument (endoscope). Step 1306 involves ablating disc tissue, and is analogous to step 1206 (FIG. 39). Before or during step 1306, an electrically conductive fluid may be applied to the disc tissue and/or the shaft in order to provide a path for current flow between active and return electrodes on the shaft, and to facilitate and/or maintain a plasma in the vicinity of the distal end portion of the shaft. After the shaft distal end has been guided to a target site and tissue at that site has been ablated, the shaft may be moved locally, e.g., within the same region of the nucleus pulposus, or to a second defined target site within the same disc. The shaft distal end may be moved as described herein (e.g., with reference to step 1210, FIG. 39). Or, according to an alternative embodiment, the shaft may be steerable, e.g., by techniques well known in the art. Steps 1310 and 1312 are analogous to steps 1212 and 1214, respectively (described with reference to FIG. 39).
It is known in the art that epidural steroid injections can transiently diminish perineural inflammation of an affected nerve root, leading to alleviation of discogenic pain. In one embodiment of the invention, methods for ablation of disc tissue described hereinabove may be conveniently performed in conjunction with an epidural steroid injection. For example, ablation of disc tissue and epidural injection could be carried out as part of a single procedure, by the same surgeon, using equipment common to both procedures (e.g. visualization equipment). Combining Coblation® and equidural injection in a single procedure may provide substantial cost-savings to the healthcare industry, as well as a significant improvement in patient care.
As alluded to hereinabove, methods and apparatus of the present invention can be used to accelerate the healing process of intervertebral discs having fissures and/or contained herniations. In one method, the present invention is useful in microendoscopic discectomy procedures, e.g., for decompressing a nerve root with a lumbar discectomy. For example, as described above in relation to
With reference to
Prior to inserting electrosurgical probe 900 into the intervertebral disc, an electrically conductive fluid can be delivered into the disk via a fluid delivery assembly (e.g., ancillary device 940) in order to facilitate or promote the Coblation® mechanism within the disc following the application of a high frequency voltage via probe 900′. By providing a separate device (940) for fluid delivery, the dimensions of electrosurgical probe 900 ′ can be kept to a minimum. Furthermore, when the fluid delivery assembly is positioned within ancillary introducer 938, electrically conductive fluid can be conveniently replenished to the interior of the disc at any given time during the procedure. Nevertheless, in other embodiments, the fluid delivery assembly can be physically coupled to electrosurgical probe 900′.
In some methods, a radiopaque contrast solution (not shown) may be delivered through a fluid delivery assembly so as to allow the surgeon to visualize the intervertebral disc under fluoroscopy. In some configurations, a tracking device 942 can be positioned on shaft distal end portion 902″a. Additionally or alternatively, shaft 902″ can be marked incrementally, e.g., with depth markings 903, to indicate to the surgeon how far the active electrode is advanced into the intervertebral disc. In one embodiment, tracking device 942 includes a radiopaque material that can be visualized under fluoroscopy. Such a tracking device 942 and depth markings 903 provide the surgeon with means to track the position of the active electrode 910 relative to a specific target site within the disc to which active electrode 910 is to be guided. Such specific target sites may include, for example, an annular fissure, a contained herniation, or a fragment of nucleus pulposus. The surgeon can determine the position of the active electrode 910 by observing the depth markings 903, or by comparing tracking device output, and a fluoroscopic image of the intervertebral disc to a pre-operative fluoroscopic image of the target intervertebral disc.
In other embodiments, an optical fiber (not shown) can be introduced into the disc. The optical fiber may be either integral with probe 900′ or may be introduced as part of an ancillary device 940 via ancillary introducer 938. In this manner, the surgeon can visually monitor the interior of the intervertebral disc and the position of active electrode 910.
In addition to monitoring the position of the distal portion of electrosurgical probe 900′, the surgeon can also monitor whether the probe is in Coblation® mode. In most embodiments, power supply 28 (e.g.,
Although active electrode 910 is shown in
While bipolar delivery of a high frequency energy is the preferred method of debulking the nucleus pulposus, it should be appreciated that other energy sources (i.e., resistive, or the like) can be used, and the energy can be delivered with other methods (i.e., monopolar, conductive, or the like) to debulk the nucleus.
In one embodiment shaft 952 has a suitable diameter and length to allow the surgeon to reach the target disc or vertebra by introducing the shaft through the thoracic cavity, the abdomen or the like. Thus, shaft 952 may have a length in the range of from about 5.0 cm to 30.0 cm, and a diameter in the range of about 0.2 mm to about 20 mm. Alternatively, shaft 952 may be delivered percutaneously in a posterior lateral approach. Regardless of the approach, shaft 952 may be introduced via a rigid or flexible endoscope. In addition, it should be noted that the methods described with reference to
Although the invention has been described primarily with respect to electrosurgical treatment of intervertebral discs, it is to be understood that the methods and apparatus of the invention are also applicable to the treatment of other tissues, organs, and bodily structures. For example, the principle of the “S-curve” configuration of the invention may be applied to any medical system or apparatus in which a medical instrument is passed within an introducer device, wherein it is desired that the distal end of the medical instrument does not contact or impinge upon the introducer device as the instrument is advanced from or retracted within the introducer device. The introducer device may be any apparatus through which a medical instrument is passed. Such a medical system or apparatus may include, for example, a catheter, a cannula, an endoscope, and the like. Thus, while the exemplary embodiments of the present invention have been described in detail, by way of example and for clarity of understanding, a variety of changes, adaptations, and modifications will be obvious to those of skill in the art. Therefore, the scope of the present invention is limited solely by the appended claims.
Hovda, David C., Thapliyal, Hira V., Eggers, Philip E., Woloszko, Jean, Sharps, Lewis
| Patent | Priority | Assignee | Title |
| 10028753, | Sep 26 2008 | Relievant Medsystems, Inc. | Spine treatment kits |
| 10045686, | Nov 12 2008 | TRICE MEDICAL, INC | Tissue visualization and modification device |
| 10076424, | Sep 07 2007 | Intrinsic Therapeutics, Inc. | Impaction systems |
| 10080600, | Jan 21 2015 | Covidien LP | Monopolar electrode with suction ability for CABG surgery |
| 10092176, | Jan 13 2014 | Trice Medical, Inc. | Fully integrated, disposable tissue visualization device |
| 10105176, | Nov 13 2009 | Minerva Surgical, Inc. | Methods and systems for endometrial ablation utilizing radio frequency |
| 10111704, | Sep 30 2002 | Relievant Medsystems, Inc. | Intraosseous nerve treatment |
| 10213246, | Nov 13 2009 | Hermes Innovations LLC | Tissue ablation systems and method |
| 10237962, | Feb 26 2014 | Covidien LP | Variable frequency excitation plasma device for thermal and non-thermal tissue effects |
| 10265099, | Sep 26 2008 | Relievant Medsystems, Inc. | Systems for accessing nerves within bone |
| 10314605, | Jul 08 2014 | SPINAL ELEMENTS, INC | Apparatus and methods for disrupting intervertebral disc tissue |
| 10327750, | Apr 16 2009 | NuVasive, Inc. | Method and apparatus for performing spine surgery |
| 10342579, | Jan 13 2014 | TRICE MEDICAL, INC | Fully integrated, disposable tissue visualization device |
| 10357258, | Nov 05 2012 | Relievant Medsystems, Inc. | Systems and methods for creating curved paths through bone |
| 10357307, | Dec 30 2010 | Avent, Inc. | Electrosurgical tissue treatment method |
| 10390877, | Dec 30 2011 | RELIEVANT MEDSYSTEMS, INC | Systems and methods for treating back pain |
| 10398298, | Jan 13 2014 | Trice Medical, Inc. | Fully integrated, disposable tissue visualization device |
| 10405886, | Aug 11 2015 | Trice Medical, Inc. | Fully integrated, disposable tissue visualization device |
| 10420607, | Feb 14 2014 | Arthrocare Corporation | Methods and systems related to an electrosurgical controller |
| 10448992, | Oct 22 2010 | Arthrocare Corporation | Electrosurgical system with device specific operational parameters |
| 10456187, | Aug 08 2013 | Relievant Medsystems, Inc. | Modulating nerves within bone using bone fasteners |
| 10463423, | Mar 28 2003 | Relievant Medsystems, Inc. | Thermal denervation devices and methods |
| 10470804, | Dec 28 2005 | Intrinsic Therapeutics, Inc. | Bone anchor delivery systems and methods |
| 10478246, | Sep 12 2012 | Relievant Medsystems, Inc. | Ablation of tissue within vertebral body involving internal cooling |
| 10492856, | Jan 26 2015 | Hermes Innovations LLC | Surgical fluid management system and method of use |
| 10517578, | Oct 15 2013 | Hermes Innovations LLC | Laparoscopic device |
| 10517611, | Nov 05 2012 | Relievant Medsystems, Inc. | Systems for navigation and treatment within a vertebral body |
| 10524849, | Aug 02 2016 | Covidien LP | System and method for catheter-based plasma coagulation |
| 10524850, | Jul 22 2008 | Covidien LP | Electrosurgical devices, systems and methods of using the same |
| 10588691, | Sep 12 2012 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
| 10617461, | Oct 21 2008 | Hermes Innovations LLC | Endometrial ablation devices and system |
| 10675087, | Apr 29 2015 | Cirrus Technologies Ltd | Medical ablation device and method of use |
| 10716685, | Sep 07 2007 | Intrinsic Therapeutics, Inc. | Bone anchor delivery systems |
| 10750605, | Feb 26 2014 | Covidien LP | Variable frequency excitation plasma device for thermal and non-thermal tissue effects |
| 10905440, | Sep 26 2008 | Relievant Medsystems, Inc. | Nerve modulation systems |
| 10912606, | Oct 21 2008 | Hermes Innovations LLC | Endometrial ablation method |
| 10945588, | Aug 11 2015 | Trice Medical, Inc. | Fully integrated, disposable tissue visualization device |
| 11007010, | Sep 12 2019 | RELIEVANT MEDSYSTEMS, INC | Curved bone access systems |
| 11065046, | Aug 08 2013 | Relievant Medsystems, Inc. | Modulating nerves within bone |
| 11123103, | Sep 12 2019 | RELIEVANT MEDSYSTEMS, INC | Introducer systems for bone access |
| 11160563, | Nov 05 2012 | Relievant Medsystems, Inc. | Systems for navigation and treatment within a vertebral body |
| 11185354, | Dec 28 2005 | Intrinsic Therapeutics, Inc. | Bone anchor delivery systems and methods |
| 11202655, | Sep 12 2019 | Relievant Medsystems, Inc. | Accessing and treating tissue within a vertebral body |
| 11207100, | Sep 12 2019 | Relievant Medsystems, Inc. | Methods of detecting and treating back pain |
| 11224453, | Jul 08 2014 | SPINAL ELEMENTS, INC | Apparatus and methods for disrupting intervertebral disc tissue |
| 11234764, | Nov 05 2012 | Relievant Medsystems, Inc. | Systems for navigation and treatment within a vertebral body |
| 11253311, | Apr 22 2016 | Relign Corporation | Arthroscopic devices and methods |
| 11259787, | Oct 15 2013 | Hermes Innovations LLC | Laparoscopic device |
| 11291502, | Nov 05 2012 | Relievant Medsystems, Inc. | Methods of navigation and treatment within a vertebral body |
| 11376058, | Aug 02 2016 | Covidien LP | System and method for catheter-based plasma coagulation |
| 11413088, | Nov 13 2009 | Minerva Surgical, Inc. | Methods and systems for endometrial ablation utilizing radio frequency |
| 11426199, | Sep 12 2019 | Relievant Medsystems, Inc. | Methods of treating a vertebral body |
| 11446157, | Apr 16 2009 | NuVasive, Inc. | Methods and apparatus of performing spine surgery |
| 11471145, | Mar 16 2018 | SPINAL ELEMENTS, INC | Articulated instrumentation and methods of using the same |
| 11471171, | Sep 26 2008 | Relievant Medsystems, Inc. | Bipolar radiofrequency ablation systems for treatment within bone |
| 11471210, | Dec 30 2011 | Relievant Medsystems, Inc. | Methods of denervating vertebral body using external energy source |
| 11547446, | Jan 13 2014 | Trice Medical, Inc. | Fully integrated, disposable tissue visualization device |
| 11554214, | Jun 26 2019 | MEDITRINA, INC | Fluid management system |
| 11564811, | Feb 06 2015 | SPINAL ELEMENTS, INC | Graft material injector system and method |
| 11576718, | Jan 20 2016 | Relign Corporation | Arthroscopic devices and methods |
| 11583327, | Jan 29 2018 | SPINAL ELEMENTS, INC | Minimally invasive interbody fusion |
| 11596468, | Sep 12 2012 | Relievant Medsystems, Inc. | Intraosseous nerve treatment |
| 11622753, | Mar 29 2018 | TRICE MEDICAL, INC | Fully integrated endoscope with biopsy capabilities and methods of use |
| 11647999, | Apr 16 2009 | NuVasive, Inc. | Method and apparatus for performing spine surgery |
| 11690667, | Sep 12 2012 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
| 11701168, | Sep 12 2012 | Relievant Medsystems, Inc. | Radiofrequency ablation of tissue within a vertebral body |
| 11737814, | Sep 12 2012 | Relievant Medsystems, Inc. | Cryotherapy treatment for back pain |
| 11766291, | Jul 01 2016 | Relign Corporation | Arthroscopic devices and methods |
| 11771483, | Mar 22 2017 | SPINAL ELEMENTS, INC | Minimal impact access system to disc space |
| 11793563, | Apr 22 2016 | Relign Corporation | Arthroscopic devices and methods |
| 11857248, | Nov 13 2009 | Minerva Surgical, Inc. | Methods and systems for endometrial ablation utilizing radio frequency |
| 11896282, | Nov 13 2009 | Hermes Innovations LLC | Tissue ablation systems and method |
| 11911086, | Oct 21 2008 | Hermes Innovations LLC | Endometrial ablation devices and systems |
| 7429260, | Jul 16 1996 | Arthrocare Corporation | Systems and methods for electrosurgical tissue contraction within the spine |
| 7507236, | Jan 07 1992 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
| 7553309, | Oct 08 2004 | TYCO HEALTHCARE GROUP AG; Covidien AG | Electrosurgical system employing multiple electrodes and method thereof |
| 7572251, | Jun 07 1995 | Arthrocare Corporation | Systems and methods for electrosurgical tissue treatment |
| 7678069, | Nov 22 1995 | Arthrocare Corporation | System for electrosurgical tissue treatment in the presence of electrically conductive fluid |
| 7691101, | Jan 06 2006 | Arthrocare Corporation | Electrosurgical method and system for treating foot ulcer |
| 7699842, | Oct 08 2004 | TYCO HEALTHCARE GROUP AG; Covidien AG | Electrosurgical system employing multiple electrodes and method thereof |
| 7708733, | Oct 20 2003 | Arthrocare Corporation | Electrosurgical method and apparatus for removing tissue within a bone body |
| 7717912, | Feb 09 2001 | Arthrocare Corporation | Bipolar electrosurgical clamp for removing and modifying tissue |
| 7758537, | Nov 22 1995 | Arthrocare Corporation | Systems and methods for electrosurgical removal of the stratum corneum |
| 7763018, | Jul 28 2006 | TYCO HEALTHCARE GROUP AG; Covidien AG | Cool-tip thermocouple including two-piece hub |
| 7776035, | Oct 08 2004 | TYCO HEALTHCARE GROUP AG; Covidien AG | Cool-tip combined electrode introducer |
| 7794456, | May 13 2003 | Arthrocare Corporation | Systems and methods for electrosurgical intervertebral disc replacement |
| 7819863, | Jan 07 1992 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
| 7824398, | Nov 22 1995 | Arthrocare Corporation | Electrosurgical systems and methods for removing and modifying tissue |
| 7824405, | Jan 07 1992 | Arthrocare Corporation | Electrosurgical apparatus and methods for laparoscopy |
| 7846108, | Apr 16 2002 | Covidien LP | Localization element with energized tip |
| 7867278, | Aug 18 1999 | Intrinsic Therapeutics, Inc. | Intervertebral disc anulus implant |
| 7879031, | Sep 27 2005 | TYCO HEALTHCARE GROUP AG; Covidien AG | Cooled RF ablation needle |
| 7879034, | Mar 02 2006 | Arthrocare Corporation | Internally located return electrode electrosurgical apparatus, system and method |
| 7879097, | Aug 18 1999 | Intrinsic Therapeutics, Inc. | Method of performing a procedure within a disc |
| 7892230, | Jun 24 2004 | Arthrocare Corporation | Electrosurgical device having planar vertical electrode and related methods |
| 7901403, | Mar 02 2006 | Arthrocare Corporation | Internally located return electrode electrosurgical apparatus, system and method |
| 7931689, | Feb 27 2001 | SPINEOLOGY, INC | Method and apparatus for treating a vertebral body |
| 7951141, | May 13 2003 | Arthrocare Corporation | Systems and methods for electrosurgical intervertebral disc replacement |
| 7959679, | Aug 18 1999 | Intrinsic Therapeutics, Inc. | Intervertebral anulus and nucleus augmentation |
| 7972337, | Dec 28 2005 | INTRINSIC THERAPEUTICS, INC | Devices and methods for bone anchoring |
| 7987614, | Apr 12 2004 | Restraining device for reducing warp in lumber during drying | |
| 7988689, | Aug 11 1998 | Arthrocare Corporation | Electrosurgical apparatus and methods for treatment and removal of tissue |
| 7998213, | Aug 18 1999 | Intrinsic Therapeutics, Inc. | Intervertebral disc herniation repair |
| 8002836, | Aug 18 1999 | Intrinsic Therapeutics, Inc. | Method for the treatment of the intervertebral disc anulus |
| 8012153, | Jul 16 2003 | Arthrocare Corporation | Rotary electrosurgical apparatus and methods thereof |
| 8021425, | Aug 18 1999 | Intrinsic Therapeutics, Inc. | Versatile method of repairing an intervertebral disc |
| 8025698, | Aug 18 1999 | INTRINSIC THERAPEUTICS, INC | Method of rehabilitating an anulus fibrosus |
| 8062290, | Oct 08 2004 | Covidien AG | Electrosurgical system employing multiple electrodes |
| 8096303, | Feb 08 2005 | Koninklijke Philips Electronics N V | Airway implants and methods and devices for insertion and retrieval |
| 8103339, | Apr 21 2008 | NEUROVISION MEDICAL PRODUCTS, INC | Nerve stimulator with suction capability |
| 8104190, | Dec 29 2006 | Signature Control Systems, Inc. | Wood kiln moisture measurement calibration and metering methods |
| 8105384, | Aug 18 1999 | INTRINSIC THERAPEUTICS, INC | Weakened anulus repair |
| 8114071, | May 30 2006 | Arthrocare Corporation | Hard tissue ablation system |
| 8114082, | Dec 28 2005 | Intrinsic Therapeutics, Inc. | Anchoring system for disc repair |
| 8152800, | Jul 30 2007 | Covidien LP | Electrosurgical systems and printed circuit boards for use therewith |
| 8181995, | Sep 07 2007 | Covidien LP | Cool tip junction |
| 8182477, | Oct 08 2004 | TYCO HEALTHCARE GROUP AG; Covidien AG | Electrosurgical system employing multiple electrodes and method thereof |
| 8192424, | Jan 05 2007 | Arthrocare Corporation | Electrosurgical system with suction control apparatus, system and method |
| 8197476, | Oct 21 2008 | Hermes Innovations LLC | Tissue ablation systems |
| 8197477, | Oct 21 2008 | Hermes Innovations LLC | Tissue ablation methods |
| 8211099, | Jan 31 2007 | Covidien LP | Thermal feedback systems and methods of using the same |
| 8231678, | Aug 18 1999 | INTRINSIC THERAPEUTICS, INC | Method of treating a herniated disc |
| 8257350, | Jun 17 2009 | Arthrocare Corporation | Method and system of an electrosurgical controller with wave-shaping |
| 8257437, | Aug 18 1999 | Intrinsic Therapeutics, Inc. | Methods of intervertebral disc augmentation |
| 8292880, | Nov 27 2007 | Covidien LP | Targeted cooling of deployable microwave antenna |
| 8292887, | Mar 02 2007 | Arthrocare Corporation | Internally located return electrode electrosurgical apparatus, system and method |
| 8317786, | Sep 25 2009 | AthroCare Corporation | System, method and apparatus for electrosurgical instrument with movable suction sheath |
| 8323279, | Sep 25 2009 | ArthoCare Corporation | System, method and apparatus for electrosurgical instrument with movable fluid delivery sheath |
| 8323341, | Sep 07 2007 | INTRINSIC THERAPEUTICS, INC | Impaction grafting for vertebral fusion |
| 8355799, | Dec 12 2008 | Arthrocare Corporation | Systems and methods for limiting joint temperature |
| 8361067, | Sep 30 2002 | Relievant Medsystems, Inc. | Methods of therapeutically heating a vertebral body to treat back pain |
| 8361155, | Sep 07 2007 | Intrinsic Therapeutics, Inc. | Soft tissue impaction methods |
| 8371307, | Feb 08 2005 | Koninklijke Philips Electronics N V | Methods and devices for the treatment of airway obstruction, sleep apnea and snoring |
| 8372067, | Dec 09 2009 | Arthrocare Corporation | Electrosurgery irrigation primer systems and methods |
| 8372068, | Oct 21 2008 | Hermes Innovations LLC | Tissue ablation systems |
| 8377057, | Oct 08 2004 | Covidien AG | Cool-tip combined electrode introducer |
| 8382753, | Oct 21 2008 | Hermes Innovations LLC | Tissue ablation methods |
| 8394146, | Dec 28 2005 | Intrinsic Therapeutics, Inc. | Vertebral anchoring methods |
| 8398626, | Oct 08 2004 | Covidien AG | Electrosurgical system employing multiple electrodes |
| 8409284, | Aug 18 1999 | Intrinsic Therapeutics, Inc. | Methods of repairing herniated segments in the disc |
| 8414571, | Jan 07 2010 | RELIEVANT MEDSYSTEMS, INC | Vertebral bone navigation systems |
| 8419730, | Sep 26 2008 | RELIEVANT MEDSYSTEMS, INC | Systems and methods for navigating an instrument through bone |
| 8419731, | Sep 30 2002 | Relievant Medsystems, Inc. | Methods of treating back pain |
| 8425507, | Sep 30 2002 | Relievant Medsystems, Inc. | Basivertebral nerve denervation |
| 8444638, | May 30 2006 | Arthrocare Corporation | Hard tissue ablation system |
| 8454612, | Sep 07 2007 | INTRINSIC THERAPEUTICS, INC | Method for vertebral endplate reconstruction |
| 8470043, | Dec 23 2008 | SPINAL ELEMENTS, INC | Tissue removal tools and methods of use |
| 8480665, | Sep 07 2007 | Covidien LP | Cool tip junction |
| 8480666, | Jan 31 2007 | Covidien LP | Thermal feedback systems and methods of using the same |
| 8500732, | Oct 21 2008 | Hermes Innovations LLC | Endometrial ablation devices and systems |
| 8529562, | Nov 13 2009 | Minerva Surgical, Inc | Systems and methods for endometrial ablation |
| 8535309, | Jan 07 2010 | RELIEVANT MEDSYSTEMS, INC | Vertebral bone channeling systems |
| 8540708, | Oct 21 2008 | Hermes Innovations LLC | Endometrial ablation method |
| 8568402, | Jan 31 2007 | Covidien LP | Thermal feedback systems and methods of using the same |
| 8568405, | Oct 15 2010 | Arthrocare Corporation | Electrosurgical wand and related method and system |
| 8574187, | Mar 09 2009 | Arthrocare Corporation | System and method of an electrosurgical controller with output RF energy control |
| 8608739, | Jul 22 2008 | Covidien LP | Electrosurgical devices, systems and methods of using the same |
| 8613744, | Sep 30 2002 | RELIEVANT MEDSYSTEMS, INC | Systems and methods for navigating an instrument through bone |
| 8623014, | Sep 26 2008 | Relievant Medsystems, Inc. | Systems for denervation of basivertebral nerves |
| 8628528, | Sep 26 2008 | Relievant Medsystems, Inc. | Vertebral denervation |
| 8636685, | Jan 06 2006 | Arthrocare Corporation | Electrosurgical method and system for treating foot ulcer |
| 8663152, | Jan 06 2006 | Arthrocare Corporation | Electrosurgical method and system for treating foot ulcer |
| 8663153, | Jan 06 2006 | Arthrocare Corporation | Electrosurgical method and system for treating foot ulcer |
| 8663154, | Jan 06 2006 | Arthrocare Corporation | Electrosurgical method and system for treating foot ulcer |
| 8663216, | Aug 11 1998 | Arthrocare Corporation | Instrument for electrosurgical tissue treatment |
| 8668688, | May 05 2006 | Covidien AG | Soft tissue RF transection and resection device |
| 8672937, | Jul 28 2006 | TYCO HEALTHCARE GROUP AG; Covidien AG | Cool-tip thermocouple including two-piece hub |
| 8685018, | Oct 15 2010 | Arthrocare Corporation | Electrosurgical wand and related method and system |
| 8690873, | Oct 21 2008 | Hermes Innovations LLC | Endometrial ablation devices and systems |
| 8696659, | Apr 30 2010 | Arthrocare Corporation | Electrosurgical system and method having enhanced temperature measurement |
| 8715278, | Nov 11 2009 | Minerva Surgical, Inc | System for endometrial ablation utilizing radio frequency |
| 8747399, | Apr 06 2010 | Arthrocare Corporation | Method and system of reduction of low frequency muscle stimulation during electrosurgical procedures |
| 8747400, | Aug 13 2008 | Arthrocare Corporation | Systems and methods for screen electrode securement |
| 8747401, | Jan 20 2011 | Arthrocare Corporation | Systems and methods for turbinate reduction |
| 8757163, | Feb 08 2005 | Koninklijke Philips N.V. | Airway implants and methods and devices for insertion and retrieval |
| 8801705, | Oct 20 2003 | Arthrocare Corporation | Electrosurgical method and apparatus for removing tissue within a bone body |
| 8808284, | Sep 26 2008 | Relievant Medsystems, Inc. | Systems for navigating an instrument through bone |
| 8821486, | Nov 13 2009 | Hermes Innovations LLC | Tissue ablation systems and methods |
| 8870866, | Jan 05 2007 | Arthrocare Corporation | Electrosurgical system with suction control apparatus, system and method |
| 8876746, | Jan 06 2006 | Arthrocare Corporation | Electrosurgical system and method for treating chronic wound tissue |
| 8882764, | Mar 28 2003 | Relievant Medsystems, Inc. | Thermal denervation devices |
| 8956348, | Jul 21 2010 | Minerva Surgical, Inc | Methods and systems for endometrial ablation |
| 8956350, | Jan 31 2007 | Covidien LP | Thermal feedback systems and methods of using the same |
| 8979838, | May 24 2010 | Arthrocare Corporation | Symmetric switching electrode method and related system |
| 8992522, | Sep 26 2008 | RELIEVANT MEDSYSTEMS, INC | Back pain treatment methods |
| 8992523, | Sep 30 2002 | Relievant Medsystems, Inc. | Vertebral treatment |
| 8998901, | Oct 21 2008 | Hermes Innovations LLC | Endometrial ablation method |
| 9011428, | Mar 02 2011 | Arthrocare Corporation | Electrosurgical device with internal digestor electrode |
| 9017325, | Sep 26 2008 | Relievant Medsystems, Inc. | Nerve modulation systems |
| 9023038, | Sep 30 2002 | Relievant Medsystems, Inc. | Denervation methods |
| 9039701, | Sep 26 2008 | Relievant Medsystems, Inc. | Channeling paths into bone |
| 9039741, | Dec 28 2005 | Intrinsic Therapeutics, Inc. | Bone anchor systems |
| 9095358, | Dec 09 2009 | Arthrocare Corporation | Electrosurgery irrigation primer systems and methods |
| 9113888, | Oct 08 2004 | Covidien AG | Electrosurgical system employing multiple electrodes and method thereof |
| 9113927, | Jan 29 2010 | Covidien LP | Apparatus and methods of use for treating blood vessels |
| 9131597, | Feb 02 2011 | Arthrocare Corporation | Electrosurgical system and method for treating hard body tissue |
| 9138282, | Jun 17 2009 | Arthrocare Corporation | Method and system of an electrosurgical controller with wave-shaping |
| 9161773, | Dec 23 2008 | SPINAL ELEMENTS, INC | Tissue removal tools and methods of use |
| 9168082, | Feb 09 2011 | Arthrocare Corporation | Fine dissection electrosurgical device |
| 9168087, | Jan 06 2006 | Arthrocare Corporation | Electrosurgical system and method for sterilizing chronic wound tissue |
| 9173676, | Sep 26 2008 | Relievant Medsystems, Inc. | Nerve modulation methods |
| 9190704, | Jul 30 2007 | Covidien LP | Electrosurgical systems and printed circuit boards for use therewith |
| 9226832, | Sep 07 2007 | Intrinsic Therapeutics, Inc. | Interbody fusion material retention methods |
| 9254164, | Jan 05 2007 | Arthrocare Corporation | Electrosurgical system with suction control apparatus, system and method |
| 9254166, | Jan 17 2013 | Arthrocare Corporation | Systems and methods for turbinate reduction |
| 9254167, | Jan 06 2006 | Arthrocare Corporation | Electrosurgical system and method for sterilizing chronic wound tissue |
| 9259241, | Sep 26 2008 | Relievant Medsystems, Inc. | Methods of treating nerves within bone using fluid |
| 9265522, | Sep 26 2008 | Relievant Medsystems, Inc. | Methods for navigating an instrument through bone |
| 9271784, | Feb 09 2011 | Arthrocare Corporation | Fine dissection electrosurgical device |
| 9289257, | Nov 13 2009 | Minerva Surgical, Inc | Methods and systems for endometrial ablation utilizing radio frequency |
| 9333087, | Aug 18 1999 | Intrinsic Therapeutics, Inc. | Herniated disc repair |
| 9345537, | Dec 30 2010 | Avent, Inc | Electrosurgical tissue treatment method |
| 9351845, | Apr 16 2009 | NuVasive, Inc | Method and apparatus for performing spine surgery |
| 9358063, | Feb 14 2008 | Arthrocare Corporation | Ablation performance indicator for electrosurgical devices |
| 9370295, | Jan 13 2014 | TRICE MEDICAL, INC | Fully integrated, disposable tissue visualization device |
| 9421064, | Sep 26 2008 | Relievant Medsystems, Inc. | Nerve modulation systems |
| 9452008, | Dec 12 2008 | Arthrocare Corporation | Systems and methods for limiting joint temperature |
| 9486269, | Jun 22 2007 | Covidien LP | Electrosurgical systems and cartridges for use therewith |
| 9486279, | Sep 30 2002 | Relievant Medsystems, Inc. | Intraosseous nerve treatment |
| 9510897, | Nov 05 2010 | Hermes Innovations LLC | RF-electrode surface and method of fabrication |
| 9526556, | Feb 28 2014 | Arthrocare Corporation | Systems and methods systems related to electrosurgical wands with screen electrodes |
| 9610007, | Jan 13 2014 | Trice Medical, Inc. | Fully integrated, disposable tissue visualization device |
| 9610106, | Dec 28 2005 | Intrinsic Therapeutics, Inc. | Bone anchor systems |
| 9636171, | Nov 13 2009 | Minerva Surgical, Inc. | Methods and systems for endometrial ablation utilizing radio frequency |
| 9649125, | Oct 15 2013 | Hermes Innovations LLC | Laparoscopic device |
| 9649144, | Jan 17 2013 | Arthrocare Corporation | Systems and methods for turbinate reduction |
| 9662163, | Oct 21 2008 | Hermes Innovations LLC | Endometrial ablation devices and systems |
| 9693818, | Mar 07 2013 | Arthrocare Corporation | Methods and systems related to electrosurgical wands |
| 9706947, | Aug 18 1999 | Intrinsic Therapeutics, Inc. | Method of performing an anchor implantation procedure within a disc |
| 9713489, | Mar 07 2013 | Arthrocare Corporation | Electrosurgical methods and systems |
| 9724107, | Sep 26 2008 | Relievant Medsystems, Inc. | Nerve modulation systems |
| 9724151, | Aug 08 2013 | RELIEVANT MEDSYSTEMS, INC | Modulating nerves within bone using bone fasteners |
| 9775627, | Nov 05 2012 | Relievant Medsystems, Inc. | Systems and methods for creating curved paths through bone and modulating nerves within the bone |
| 9788882, | Sep 08 2011 | Arthrocare Corporation | Plasma bipolar forceps |
| 9801678, | Mar 13 2013 | Arthrocare Corporation | Method and system of controlling conductive fluid flow during an electrosurgical procedure |
| 9833287, | Jan 31 2007 | Covidien LP | Thermal feedback systems and methods of using the same |
| 9848932, | Jul 28 2006 | Covidien AG | Cool-tip thermocouple including two-piece hub |
| 9848944, | Mar 28 2003 | Relievant Medsystems, Inc. | Thermal denervation devices and methods |
| 9877769, | Jul 22 2008 | Covidien LP | Electrosurgical devices, systems and methods of using the same |
| 9888962, | Jan 29 2010 | Covidien LP | Apparatus and method of use for treating blood vessels |
| 9901394, | Apr 04 2013 | Hermes Innovations LLC | Medical ablation system and method of making |
| 9962150, | Dec 20 2013 | Arthrocare Corporation | Knotless all suture tissue repair |
| D658760, | Oct 15 2010 | Arthrocare Corporation | Wound care electrosurgical wand |
| RE46356, | Sep 30 2002 | Relievant Medsystems, Inc. | Method of treating an intraosseous nerve |
| RE48460, | Sep 30 2002 | Relievant Medsystems, Inc. | Method of treating an intraosseous nerve |
| Patent | Priority | Assignee | Title |
| 2056377, | |||
| 3633425, | |||
| 3815604, | |||
| 3828780, | |||
| 3901242, | |||
| 3920021, | |||
| 3939839, | Jun 26 1974 | CIRCON CORPORATION, A CORP OF CA | Resectoscope and electrode therefor |
| 3970088, | Aug 28 1974 | Valleylab, Inc. | Electrosurgical devices having sesquipolar electrode structures incorporated therein |
| 4040426, | Jan 16 1976 | Valleylab, Inc. | Electrosurgical method and apparatus for initiating an electrical discharge in an inert gas flow |
| 4043342, | Aug 28 1974 | Valleylab, Inc. | Electrosurgical devices having sesquipolar electrode structures incorporated therein |
| 4074718, | Mar 17 1976 | Valleylab, Inc. | Electrosurgical instrument |
| 4092986, | Jun 14 1976 | COLTENE WHALEDENT INC | Constant output electrosurgical unit |
| 4116198, | May 15 1975 | DELMA, elektro und medizinische Apparatebaugesellschaft m.b.H. | Electro - surgical device |
| 4161950, | Aug 01 1975 | The United States of America as represented by the United States | Electrosurgical knife |
| 4181131, | Feb 28 1977 | Olympus Optical Co., Ltd. | High frequency electrosurgical instrument for cutting human body cavity structures |
| 4184492, | Aug 07 1975 | Karl Storz Endoscopy-America, Inc. | Safety circuitry for high frequency cutting and coagulating devices |
| 4202337, | Jun 14 1976 | CONCEPT, INC , 12707 U S 19 SOUTH, CLEARWATER, FLORIDA 33546 A FLORIDA CORP | Bipolar electrosurgical knife |
| 4228800, | Jun 14 1976 | CONCEPT, INC , 12707 U S 19 SOUTH, CLEARWATER, FLORIDA 33546 A FLORIDA CORP | Bipolar electrosurgical knife |
| 4232676, | Nov 16 1978 | Corning Glass Works | Surgical cutting instrument |
| 4248231, | Nov 16 1978 | Corning Glass Works | Surgical cutting instrument |
| 4269174, | Aug 06 1979 | Medical Dynamics, Inc. | Transcutaneous vasectomy apparatus and method |
| 4326529, | May 26 1978 | UNITED STATES AMERICA, THE, AS REPRESENTED BY THE DEPARTMENT OF ENERGY | Corneal-shaping electrode |
| 4381007, | Apr 30 1981 | United States Department of Energy | Multipolar corneal-shaping electrode with flexible removable skirt |
| 4449926, | Sep 02 1980 | Dental electrosurgery electrodes and method of use | |
| 4474179, | May 20 1981 | Oswald Leibinger GmbH | Method and apparatus for the high frequency coagulation of protein for surgical purposes |
| 4476862, | Feb 05 1979 | Method of scleral marking | |
| 4483338, | Jun 12 1981 | Medtronic, Inc | Bi-Polar electrocautery needle |
| 4532924, | May 13 1980 | Baxter International Inc | Multipolar electrosurgical device and method |
| 4548207, | Nov 17 1982 | XOMED, INC | Disposable coagulator |
| 4567890, | Aug 09 1983 | Pair of bipolar diathermy forceps for surgery | |
| 4573448, | Oct 05 1983 | HOWMEDICA OSTEONICS CORP | Method for decompressing herniated intervertebral discs |
| 4582057, | Mar 20 1980 | Regents of the University of Washington | Fast pulse thermal cautery probe |
| 4590934, | May 18 1983 | VALLEY FORGE SCIENTIFIC CORP , 2570 BOULEVARD OF THE GENERALS, NORRISTOWN, PA 19403; MALIS, LEONARD I , 219-44 PECK AVENUE, HOLLIS, HILLS, NY, 11427; PACKAGING SERVICE CORPORATION OF KENTUCKY, 3001 WEST KENTUCKY STREET, LOUISVILLE, KY 40211, A KY CORP | Bipolar cutter/coagulator |
| 4593691, | Jul 13 1983 | CONCEPT, INC , 12707 U S 19 SOUTH, CLEARWATER, FLORIDA 33546 A FLORIDA CORP | Electrosurgery electrode |
| 4658817, | Apr 01 1985 | Children's Hospital Medical Center | Method and apparatus for transmyocardial revascularization using a laser |
| 4660571, | Jul 18 1985 | DESAI, JAWAHAR M , M D | Percutaneous lead having radially adjustable electrode |
| 4674499, | Feb 05 1979 | Coaxial bipolar probe | |
| 4682596, | May 22 1984 | CORDIS WEBSTER, INC | Electrosurgical catheter and method for vascular applications |
| 4706667, | Jun 25 1984 | Berchtold Medizin-Elektronik GmbH & Co. | Electro surgical high frequency cutting instrument |
| 4727874, | Sep 10 1984 | WELLS FARGO BANK, NATIONAL ASSOCIATION FLAIR INDUSTRIAL PARK RCBO | Electrosurgical generator with high-frequency pulse width modulated feedback power control |
| 4765331, | Feb 10 1987 | GYRUS ACMI, INC | Electrosurgical device with treatment arc of less than 360 degrees |
| 4785823, | Jul 21 1987 | Robert F., Shaw | Methods and apparatus for performing in vivo blood thermodilution procedures |
| 4805616, | Feb 05 1979 | Bipolar probes for ophthalmic surgery and methods of performing anterior capsulotomy | |
| 4823791, | May 08 1987 | Conmed Corporation | Electrosurgical probe apparatus |
| 4832048, | Oct 29 1987 | CORDIS WEBSTER, INC | Suction ablation catheter |
| 4896671, | Aug 01 1988 | C R BARD, INC , A NEW JERSEY CORP | Catheter with contoured ablation electrode |
| 4907589, | Apr 29 1988 | Sherwood Services AG | Automatic over-temperature control apparatus for a therapeutic heating device |
| 4920978, | Aug 31 1988 | Triangle Research and Development Corporation | Method and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia |
| 4931047, | Sep 30 1987 | INTEGRA LIFESCIENCES IRELAND LTD | Method and apparatus for providing enhanced tissue fragmentation and/or hemostasis |
| 4936281, | Apr 13 1989 | Everest Medical Corporation | Ultrasonically enhanced RF ablation catheter |
| 4936301, | Jun 23 1987 | Concept, Inc. | Electrosurgical method using an electrically conductive fluid |
| 4943290, | Jun 23 1987 | Concept Inc. | Electrolyte purging electrode tip |
| 4958539, | Feb 29 1988 | Everest Medical Corporation | Method of making an electrosurgical spatula blade |
| 4966597, | Nov 04 1988 | Sherwood Services AG | Thermometric cardiac tissue ablation electrode with ultra-sensitive temperature detection |
| 4967765, | Jul 28 1988 | AMS Research Corporation | Urethral inserted applicator for prostate hyperthermia |
| 4976709, | Sep 27 1985 | RJW ACQUISTIONS, L C , D B A 20 20 TECHNOLOGIES, INC | Method for collagen treatment |
| 4976711, | Apr 13 1989 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
| 4979948, | Apr 13 1989 | PURDUE RESEARCH FOUNDATION, WEST LAFAYETTE, IN A CORP OF IN | Method and apparatus for thermally destroying a layer of an organ |
| 4998933, | Jun 10 1988 | Arthrocare Corporation | Thermal angioplasty catheter and method |
| 5007908, | Sep 29 1989 | GYRUS ACMI, INC | Electrosurgical instrument having needle cutting electrode and spot-coag electrode |
| 5009656, | Aug 17 1989 | XOMED, INC | Bipolar electrosurgical instrument |
| 5035696, | Feb 02 1990 | GYRUS MEDICAL, INC | Electrosurgical instrument for conducting endoscopic retrograde sphincterotomy |
| 5047026, | Sep 29 1989 | GYRUS MEDICAL, INC | Electrosurgical implement for tunneling through tissue |
| 5047027, | Apr 20 1990 | GYRUS MEDICAL, INC | Tumor resector |
| 5078717, | Apr 13 1989 | GYRUS MEDICAL, INC | Ablation catheter with selectively deployable electrodes |
| 5080660, | May 11 1990 | Applied Medical Resources Corporation | Electrosurgical electrode |
| 5084044, | Jul 14 1989 | GYRUS ACMI, INC | Apparatus for endometrial ablation and method of using same |
| 5085659, | Nov 21 1990 | Everest Medical Corporation | Biopsy device with bipolar coagulation capability |
| 5088997, | Mar 15 1990 | Covidien AG; TYCO HEALTHCARE GROUP AG | Gas coagulation device |
| 5098431, | Apr 13 1989 | Everest Medical Corporation | RF ablation catheter |
| 5099840, | Jan 20 1988 | G2 Design Limited | Diathermy unit |
| 5102410, | Feb 26 1990 | Laserscope | Soft tissue cutting aspiration device and method |
| 5108391, | May 09 1988 | KARL STORZ ENDOSCOPY-AMERICA, INC | High-frequency generator for tissue cutting and for coagulating in high-frequency surgery |
| 5112330, | Sep 16 1988 | Olympus Optical Co., Ltd. | Resectoscope apparatus |
| 5122138, | Nov 28 1990 | Tissue vaporizing accessory and method for an endoscope | |
| 5125928, | Sep 10 1990 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
| 5137530, | Sep 27 1985 | RJW ACQUISTIONS, L C , D B A 20 20 TECHNOLOGIES, INC | Collagen treatment apparatus |
| 5156151, | Feb 15 1991 | Boston Scientific Scimed, Inc | Endocardial mapping and ablation system and catheter probe |
| 5167659, | May 16 1990 | Aloka Co., Ltd. | Blood coagulating apparatus |
| 5171311, | Apr 30 1990 | Everest Medical Corporation | Percutaneous laparoscopic cholecystectomy instrument |
| 5178620, | Jun 10 1988 | Arthrocare Corporation | Thermal dilatation catheter and method |
| 5190517, | Jun 06 1991 | INTEGRA LIFESCIENCES IRELAND LTD | Electrosurgical and ultrasonic surgical system |
| 5192280, | Nov 25 1991 | GYRUS MEDICAL, INC | Pivoting multiple loop bipolar cutting device |
| 5195959, | May 31 1991 | Paul C., Smith | Electrosurgical device with suction and irrigation |
| 5197466, | Jan 21 1983 | MED Institute Inc. | Method and apparatus for volumetric interstitial conductive hyperthermia |
| 5197963, | Dec 02 1991 | GYRUS ACMI, INC | Electrosurgical instrument with extendable sheath for irrigation and aspiration |
| 5201729, | Jan 12 1990 | Laserscope | Method for performing percutaneous diskectomy using a laser |
| 5207675, | Jul 15 1991 | AMERICAN SURGICAL INNOVATIONS, LLC | Surgical coagulation device |
| 5207684, | Apr 13 1992 | BALLARD PURCHASE CORPORATION; NEURO NAVIGATIONAL, L L C | Sheath for shunt placement for hydrocephalus |
| 5217457, | Mar 15 1990 | Covidien AG; TYCO HEALTHCARE GROUP AG | Enhanced electrosurgical apparatus |
| 5217459, | Aug 27 1991 | Method and instrument for performing eye surgery | |
| 5230334, | Jan 22 1992 | Summit Technology, Inc. | Method and apparatus for generating localized hyperthermia |
| 5261410, | Feb 07 1991 | Research Foundation of City College of New York | Method for determining if a tissue is a malignant tumor tissue, a benign tumor tissue, or a normal or benign tissue using Raman spectroscopy |
| 5267994, | Feb 10 1992 | Conmed Corporation | Electrosurgical probe |
| 5267997, | Jan 16 1991 | ERBE ELEKTROMEDIZIN GMBH A LIMITED LIABILITY COMPANY OF THE FED REP OF GERMANY | High-frequency electrosurgery apparatus with limitation of effective value of current flowing through a surgical instrument |
| 5273524, | Oct 09 1991 | Ethicon, Inc | Electrosurgical device |
| 5277201, | May 01 1992 | Covidien AG; TYCO HEALTHCARE GROUP AG | Endometrial ablation apparatus and method |
| 5281216, | Mar 31 1992 | Covidien AG; TYCO HEALTHCARE GROUP AG | Electrosurgical bipolar treating apparatus |
| 5290273, | Aug 12 1991 | Cynosure, Inc | Laser treatment method for removing pigement containing lesions from the skin of a living human |
| 5290282, | Jun 26 1992 | CASSCELLS, CHRISTOPHER D M D | Coagulating cannula |
| 5300069, | Aug 12 1992 | Electrosurgical apparatus for laparoscopic procedures and method of use | |
| 5306238, | Mar 16 1990 | BIRTCHER MEDICAL SYSTEMS, INC | Laparoscopic electrosurgical pencil |
| 5312400, | Oct 09 1992 | Symbiosis Corporation | Cautery probes for endoscopic electrosurgical suction-irrigation instrument |
| 5314406, | Oct 09 1992 | Symbiosis Corporation | Endoscopic electrosurgical suction-irrigation instrument |
| 5318564, | May 01 1992 | HEMOSTATIC SURGERY CORPORATION, A CAYMAN ISLANDS COMPANY | Bipolar surgical snare and methods of use |
| 5324254, | May 25 1990 | Tool for laparoscopic surgery | |
| 5330470, | Jul 04 1991 | DELMA ELEKTRO- UND MEDINZINISCHE APPARATEBAU GESELLSCHAFT MBH | Electro-surgical treatment instrument |
| 5334140, | May 25 1990 | Tool for laparoscopic surgery | |
| 5336443, | Feb 22 1993 | Shin-Etsu Polymer Co., Ltd. | Anisotropically electroconductive adhesive composition |
| 5342357, | Nov 13 1992 | American Cardiac Ablation Co., Inc.; AMERICAN CARDIAC ABLATION CO , INC | Fluid cooled electrosurgical cauterization system |
| 5366443, | Jan 07 1992 | Arthrocare Corporation | Method and apparatus for advancing catheters through occluded body lumens |
| 5370675, | Aug 12 1992 | VENTURE LENDING & LEASING, INC | Medical probe device and method |
| 5374261, | Jul 24 1990 | Multifunctional devices for use in endoscopic surgical procedures and methods-therefor | |
| 5374265, | Sep 27 1985 | RJW ACQUISTIONS, L C , D B A 20 20 TECHNOLOGIES, INC | Collagen treatment apparatus and method |
| 5375588, | Aug 17 1992 | Method and apparatus for use in endoscopic procedures | |
| 5380277, | May 25 1990 | Tool for laparoscopic surgery | |
| 5380316, | Dec 18 1990 | HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT | Method for intra-operative myocardial device revascularization |
| 5383876, | Nov 13 1992 | American Cardiac Ablation Co., Inc. | Fluid cooled electrosurgical probe for cutting and cauterizing tissue |
| 5383917, | Jul 05 1991 | MORVIL TECHNOLOGY LLC | Device and method for multi-phase radio-frequency ablation |
| 5389096, | Dec 18 1990 | HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT | System and method for percutaneous myocardial revascularization |
| 5395312, | Mar 02 1993 | Allegiance Healthcare Corporation | Surgical tool |
| 5400267, | Dec 08 1992 | Hemostatix Corporation | Local in-device memory feature for electrically powered medical equipment |
| 5401272, | Sep 25 1992 | Hologic, Inc; Biolucent, LLC; Cytyc Corporation; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC ; Third Wave Technologies, INC; Gen-Probe Incorporated | Multimodality probe with extendable bipolar electrodes |
| 5403311, | Mar 29 1993 | Boston Scientific Scimed, Inc | Electro-coagulation and ablation and other electrotherapeutic treatments of body tissue |
| 5417687, | Apr 30 1993 | Ethicon Endo-Surgery, Inc | Bipolar electrosurgical trocar |
| 5419767, | Oct 09 1992 | Arthrocare Corporation | Methods and apparatus for advancing catheters through severely occluded body lumens |
| 5423810, | Feb 27 1992 | G2 Design Limited | Cauterising apparatus |
| 5423882, | Dec 26 1991 | CORDIS WEBSTER, INC | Catheter having electrode with annular recess and method of using same |
| 5433739, | Nov 02 1993 | Covidien AG; TYCO HEALTHCARE GROUP AG | Method and apparatus for heating an intervertebral disc for relief of back pain |
| 5436566, | Mar 17 1992 | Conmed Corporation | Leakage capacitance compensating current sensor for current supplied to medical device loads |
| 5437662, | Nov 13 1992 | American Cardiac Ablation Co., Inc. | Fluid cooled electrosurgical cauterization system |
| 5438302, | Jul 12 1993 | GYRUS MEDICAL LIMITED CHARTERHOUSE | Electrosurgical radiofrequency generator having regulated voltage across switching device |
| 5439446, | Jun 30 1994 | Boston Scientific Scimed, Inc | Stent and therapeutic delivery system |
| 5441499, | Jul 14 1993 | Dekna elektro-u. medizinische Apparatebau Gesellschaft mbH | Bipolar radio-frequency surgical instrument |
| 5451224, | Feb 27 1992 | G2 Design Limited | Apparatus for radio frequency bipolar electrosurgery |
| 5454809, | Jan 06 1989 | Angioplasty Systems, Inc. | Electrosurgical catheter and method for resolving atherosclerotic plaque by radio frequency sparking |
| 5458596, | May 06 1994 | Oratec Interventions, Inc | Method and apparatus for controlled contraction of soft tissue |
| 5496312, | Oct 07 1993 | Covidien AG; TYCO HEALTHCARE GROUP AG | Impedance and temperature generator control |
| 5496314, | May 01 1992 | HEMOSTATIC SURGERY CORPORATION, A CAYMAN ISLANDS COMPANY | Irrigation and shroud arrangement for electrically powered endoscopic probes |
| 5496317, | May 04 1993 | Gyrus Medical Limited | Laparoscopic surgical instrument |
| 5514130, | Oct 11 1994 | Oratec Interventions, Inc | RF apparatus for controlled depth ablation of soft tissue |
| 5542945, | Oct 05 1993 | INTEGRA ME GMBH | Electro-surgical radio-frequency instrument |
| 5554152, | Dec 18 1990 | HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT | Method for intra-operative myocardial revascularization |
| 5556397, | Oct 26 1994 | Laser Centers of America | Coaxial electrosurgical instrument |
| 5562703, | Jun 14 1994 | Endoscopic surgical instrument | |
| 5569242, | May 06 1994 | Syneron Medical, Ltd | Method and apparatus for controlled contraction of soft tissue |
| 5571100, | Nov 01 1993 | Gyrus Medical Limited | Electrosurgical apparatus |
| 5571189, | May 20 1994 | SPINEOLOGY, INC | Expandable fabric implant for stabilizing the spinal motion segment |
| 5584872, | Nov 13 1992 | SciMed Life Systems, Inc. | Electrophysiology energy treatment devices and methods of use |
| 5609151, | Sep 08 1994 | Medtronic, Inc. | Method for R-F ablation |
| 5617854, | Jun 22 1994 | Cardiac Pacemakers, Inc | Shaped catheter device and method |
| 5626136, | Apr 28 1993 | Cordis Webster, Inc.; CORDIS WEBSTER, INC | Electrophysiology catheter with pre-curved circular tip |
| 5626576, | Jan 06 1989 | ADVANCED CORONARY INTERVENTION, INC | Electrosurgical catheter for resolving atherosclerotic plaque by radio frequency sparking |
| 5633578, | Jun 07 1991 | Hemostatic Surgery Corporation | Electrosurgical generator adaptors |
| 5647869, | Jun 29 1994 | Gyrus Medical Limited | Electrosurgical apparatus |
| 5660836, | May 05 1995 | THERMAGE, INC | Method and apparatus for controlled contraction of collagen tissue |
| 5662680, | Oct 18 1991 | Endoscopic surgical instrument | |
| 5676693, | Nov 13 1992 | Boston Scientific Scimed, Inc | Electrophysiology device |
| 5681282, | Jan 07 1992 | Arthrocare Corporation | Methods and apparatus for ablation of luminal tissues |
| 5683366, | Jan 07 1992 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
| 5697281, | Oct 09 1991 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
| 5697536, | Jan 07 1992 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
| 5697882, | Jan 07 1992 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
| 5697909, | May 10 1994 | Arthrocare Corporation | Methods and apparatus for surgical cutting |
| 5700262, | Oct 16 1995 | BALLARD PURCHASE CORPORATION; NEURO NAVIGATIONAL, L L C | Bipolar electrode with fluid channels for less invasive neurosurgery |
| 5720744, | Jun 06 1995 | Covidien AG; TYCO HEALTHCARE GROUP AG | Control system for neurosurgery |
| 5725524, | Sep 08 1994 | Medtronic, Inc. | Apparatus for R-F ablation |
| 5762629, | Oct 30 1991 | HOWMEDICA OSTEONICS CORP | Oval cannula assembly and method of use |
| 5766153, | Jun 02 1995 | Arthrocare Corporation | Methods and apparatus for surgical cutting |
| 5766252, | Jan 24 1995 | HOWMEDICA OSTEONICS CORP | Interbody spinal prosthetic implant and method |
| 5785705, | Oct 11 1994 | Oratec Interventions, Inc. | RF method for controlled depth ablation of soft tissue |
| 5807306, | Nov 09 1992 | VENTION MEDICAL ADVANCED COMPONENTS, INC | Polymer matrix drug delivery apparatus |
| 5807395, | Aug 27 1993 | Medtronic, Inc. | Method and apparatus for RF ablation and hyperthermia |
| 5810764, | Jan 07 1992 | Arthrocare Corporation | Resecting loop electrode and method for electrosurgical cutting and ablation |
| 5810809, | Jan 13 1997 | Enhanced Orthopaedic Technologies, Inc. | Arthroscopic shaver incorporating electrocautery |
| 5820580, | May 03 1996 | GYRUS ACMI, INC | Method for ablating interior sections of the tongue |
| 5823955, | Nov 20 1995 | Medtronic CardioRhythm | Atrioventricular valve tissue ablation catheter and method |
| 5836875, | Oct 04 1996 | CORDIS WEBSTER, INC | Split tip electrode catheter |
| 5843019, | Jan 07 1992 | Arthrocare Corporation | Shaped electrodes and methods for electrosurgical cutting and ablation |
| 5846196, | Dec 13 1995 | CORDIS EUROPA, N V | Intravascular multielectrode cardiac mapping probe |
| 5849009, | Aug 02 1994 | Flexible probe for high frequency skin treatment | |
| 5860951, | Jan 07 1992 | Arthrocare Corporation | Systems and methods for electrosurgical myocardial revascularization |
| 5860974, | Jul 01 1993 | Boston Scientific Scimed, Inc | Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft |
| 5860975, | Dec 21 1994 | Gyrus Medical Limited | Electrosurgical instrument |
| 5871469, | Jan 07 1992 | Arthro Care Corporation | System and method for electrosurgical cutting and ablation |
| 5873855, | Jan 07 1992 | Arthrocare Corporation | Systems and methods for electrosurgical myocardial revascularization |
| 5877289, | Mar 05 1992 | SCRIPPS RESEARCH INSTITUTE, THE | Tissue factor compositions and ligands for the specific coagulation of vasculature |
| 5885277, | Jul 15 1994 | OLYMPUS WINTER & IBE GMBH | High-frequency surgical instrument for minimally invasive surgery |
| 5888198, | Jan 07 1992 | Arthrocare Corporation | Electrosurgical system for resection and ablation of tissue in electrically conductive fluids |
| 5891095, | May 10 1993 | Arthrocare Corporation | Electrosurgical treatment of tissue in electrically conductive fluid |
| 5891134, | Sep 24 1996 | Ethicon, Inc | System and method for applying thermal energy to tissue |
| 5897553, | Nov 02 1995 | Medtronic, Inc | Ball point fluid-assisted electrocautery device |
| 5902272, | Jan 07 1992 | ARTHROCARE CORPORATIN | Planar ablation probe and method for electrosurgical cutting and ablation |
| 5916214, | May 01 1995 | Medtronic CardioRhythm | Dual curve ablation catheter |
| 5925042, | Aug 15 1995 | AngioDynamics, Inc | Multiple antenna ablation apparatus and method |
| 5941869, | Feb 12 1997 | PROLIFIX MEDICAL, INC | Apparatus and method for controlled removal of stenotic material from stents |
| 5944715, | Jun 29 1996 | Gyrus Medical Limited | Electrosurgical instrument |
| 5954716, | Feb 19 1998 | Oratec Interventions, Inc | Method for modifying the length of a ligament |
| 5980504, | Oct 23 1996 | NEUROTHERM, INC | Method for manipulating tissue of an intervertebral disc |
| 6004319, | Jun 23 1995 | Gyrus Medical Limited | Electrosurgical instrument |
| 6007570, | Oct 23 1996 | NEUROTHERM, INC | Apparatus with functional element for performing function upon intervertebral discs |
| 6013076, | Jan 09 1996 | Gyrus Medical Limited | Electrosurgical instrument |
| 6014584, | Aug 01 1997 | OncoSec Medical Incorporated | Electroporation therapy apparatus |
| 6015406, | Jan 09 1996 | Gyrus Medical Limited | Electrosurgical instrument |
| 6024733, | Jan 07 1992 | Arthrocare Corporation | System and method for epidermal tissue ablation |
| 6027501, | Jun 23 1995 | Gyrus Medical Limited | Electrosurgical instrument |
| 6036681, | Feb 10 1995 | Atricure, Inc | Apparatus and method for morselating and removing tissue from a patient |
| 6039734, | Oct 24 1995 | Gyrus Medical Limited | Electrosurgical hand-held battery-operated instrument |
| 6045532, | Feb 20 1998 | Arthrocare Corporation | Systems and methods for electrosurgical treatment of tissue in the brain and spinal cord |
| 6047700, | Mar 30 1998 | Arthrocare Corporation | Systems and methods for electrosurgical removal of calcified deposits |
| 6056746, | Jun 23 1995 | Gyrus Medical Limited | Electrosurgical instrument |
| 6063079, | Dec 15 1997 | Arthrocare Corporation | Methods for electrosurgical treatment of turbinates |
| 6066134, | Jan 07 1992 | Arthrocare Corporation | Method for electrosurgical cutting and ablation |
| 6068628, | Aug 20 1996 | Oratec Interventions, Inc | Apparatus for treating chondromalacia |
| 6073051, | Jun 24 1997 | NEUROTHERM, INC | Apparatus for treating intervertebal discs with electromagnetic energy |
| 6074386, | Dec 29 1995 | Gyrus Medical Limited | Electrosurgical instrument and an electrosurgical electrode assembly |
| 6086584, | Sep 10 1998 | Ethicon, Inc | Cellular sublimation probe and methods |
| 6090106, | Jan 09 1996 | Gyrus Medical Limited | Electrosurgical instrument |
| 6093186, | Dec 20 1996 | Gyrus Medical Limited | Electrosurgical generator and system |
| 6093187, | Apr 03 1997 | ELEKTA IMPLANTS S A | Catheter for neurosurgery |
| 6095149, | Oct 23 1996 | NEUROTHERM, INC | Method for treating intervertebral disc degeneration |
| 6096036, | May 05 1998 | Cardiac Pacemakers, Inc | Steerable catheter with preformed distal shape and method for use |
| 6102046, | Nov 22 1995 | Arthrocare Corporation | Systems and methods for electrosurgical tissue revascularization |
| 6105581, | Jan 07 1992 | ArthoCare Corporation | Electrosurgical systems and methods for treating the spine |
| 6109268, | Jun 07 1995 | Arthrocare Corporation | Systems and methods for electrosurgical endoscopic sinus surgery |
| 6117109, | Nov 25 1997 | Arthrocare Corporation | Systems and methods for electrosurgical incisions on external skin surfaces |
| 6122549, | Oct 23 1996 | NEUROTHERM, INC | Apparatus for treating intervertebral discs with resistive energy |
| 6126682, | Oct 23 1996 | NEUROTHERM, INC | Method for treating annular fissures in intervertebral discs |
| 6142992, | May 10 1993 | Arthrocare Corporation | Power supply for limiting power in electrosurgery |
| 6146380, | Jan 09 1998 | Covidien AG; TYCO HEALTHCARE GROUP AG | Bent tip electrical surgical probe |
| 6149620, | Nov 22 1995 | Arthrocare Corporation | System and methods for electrosurgical tissue treatment in the presence of electrically conductive fluid |
| 6159194, | Oct 02 1997 | Arthrocare Corporation | System and method for electrosurgical tissue contraction |
| 6159208, | Dec 15 1997 | ArthoCare Corporation | System and methods for electrosurgical treatment of obstructive sleep disorders |
| 6168593, | Feb 12 1997 | Oratec Interventions, Inc. | Electrode for electrosurgical coagulation of tissue |
| 6174309, | Feb 11 1999 | ERBE ELEKTROMEDIZIN GMBH | Seal & cut electrosurgical instrument |
| 6176857, | Sep 22 1998 | Oratec Interventions, Inc. | Method and apparatus for applying thermal energy to tissue asymmetrically |
| 6179824, | May 10 1993 | Arthrocare Corporation | System and methods for electrosurgical restenosis of body lumens |
| 6179836, | Jan 07 1992 | Arthrocare Corporation | Planar ablation probe for electrosurgical cutting and ablation |
| 6183469, | Aug 27 1997 | Arthrocare Corporation | Electrosurgical systems and methods for the removal of pacemaker leads |
| 6190381, | Jun 07 1995 | Arthrocare Corporation | Methods for tissue resection, ablation and aspiration |
| 6203542, | Jun 07 1995 | Arthrocare Corporation | Method for electrosurgical treatment of submucosal tissue |
| 6210402, | Nov 22 1995 | Arthrocare Corporation | Methods for electrosurgical dermatological treatment |
| 6214001, | Sep 19 1997 | Oratec Interventions, Inc. | Electrocauterizing tool for orthopedic shave devices |
| 6224592, | Jan 07 1992 | Arthrocare Corporation | Systems and methods for electrosurgical tissue treatment in conductive fluid |
| 6228078, | Nov 22 1995 | Arthrocare Corporation | Methods for electrosurgical dermatological treatment |
| 6228081, | May 21 1999 | Gyrus Medical Limited | Electrosurgery system and method |
| 6234178, | Jan 09 1996 | Gyrus Medical Limited | Electrosurgical instrument |
| 6235020, | May 10 1993 | Arthrocare Corporation | Power supply and methods for fluid delivery in electrosurgery |
| 6237604, | Sep 07 1999 | Boston Scientific Scimed, Inc | Systems and methods for preventing automatic identification of re-used single use devices |
| 6238391, | Jun 07 1995 | Arthrocare Corporation | Systems for tissue resection, ablation and aspiration |
| 6245107, | May 28 1999 | Anova Corporation | Methods and apparatus for treating disc herniation |
| 6254600, | May 10 1993 | Arthrocare Corporation | Systems for tissue ablation and aspiration |
| 6258086, | Oct 23 1996 | NEUROTHERM, INC | Catheter for delivery of energy to a surgical site |
| 6261286, | Jun 23 1995 | Gyrus Medical Limited | Electrosurgical generator and system |
| 6261311, | Oct 23 1996 | NEUROTHERM, INC | Method and apparatus for treating intervertebral discs |
| 6264650, | Jun 07 1995 | Arthrocare Corporation | Methods for electrosurgical treatment of intervertebral discs |
| 6264651, | Jul 18 1996 | Arthrocare Corporation | Method for electrosurgical spine surgery |
| 6264652, | Nov 25 1997 | Arthro Care Corporation | Electrosurgical systems for treating tissue |
| 6270460, | Jun 24 1999 | Siemens Medical Solutions USA, Inc | Apparatus and method to limit the life span of a diagnostic medical ultrasound probe |
| 6277112, | Jul 18 1996 | Arthrocare Corporation | Methods for electrosurgical spine surgery |
| 6280441, | Dec 15 1997 | Covidien AG; TYCO HEALTHCARE GROUP AG | Apparatus and method for RF lesioning |
| 6283961, | Jul 18 1996 | Arthrocare Corporation | Apparatus for electrosurgical spine surgery |
| 6293942, | Jun 23 1995 | Gyrus Medical Limited | Electrosurgical generator method |
| 6296636, | Jun 07 1995 | Arthrocare Corporation | Power supply and methods for limiting power in electrosurgery |
| 6296638, | May 10 1993 | Arthrocare Corporation | Systems for tissue ablation and aspiration |
| 6306134, | Jun 23 1995 | Gyrus Medical Limited | Electrosurgical generator and system |
| 6308089, | Apr 14 1999 | Masimo Corporation | Limited use medical probe |
| 6309387, | Nov 25 1997 | Arthrocare Corporation | Systems and methods for electrosurgical skin resurfacing |
| 6312408, | Jan 07 1992 | Arthrocare Corporation | Electrosurgical probe for treating tissue in electrically conductive fluid |
| 6319250, | Nov 23 1998 | Boston Scientific Scimed, Inc | Tricuspid annular grasp catheter |
| 6322549, | Feb 20 1998 | ArthoCare Corporation | Systems and methods for electrosurgical treatment of tissue in the brain and spinal cord |
| 6330478, | Nov 03 1997 | AngioDynamics, Inc | Cell necrosis apparatus |
| 6355032, | Jun 07 1995 | Arthrocare Corporation | Systems and methods for selective electrosurgical treatment of body structures |
| 6363937, | Jun 07 1995 | Arthrocare Corporation | System and methods for electrosurgical treatment of the digestive system |
| 6364877, | Jun 23 1995 | Gyrus Medical Limited | Electrosurgical generator and system |
| 6379351, | Aug 27 1997 | Arthrocare Corporation | Electrosurgical method for the removal of pacemaker leads |
| 6391025, | May 10 1993 | Arthrocare Corporation | Electrosurgical scalpel and methods for tissue cutting |
| 6402740, | Mar 05 1998 | Boston Scientific Scimed, Inc | Expandable PMR device and method |
| 6416507, | Jan 07 1992 | Arthrocare Corporation | Method for treating articular cartilage defects |
| 6416508, | May 10 1993 | Arthrocare Corporation | Methods for electrosurgical tissue treatment in conductive fluid |
| 6416509, | Jun 23 1995 | Gyrus Medical Limited | Electrosurgical generator and system |
| 6428576, | Apr 16 1999 | PAUZA, KEVIN | System for repairing inter-vertebral discs |
| 6432103, | Jun 07 1995 | Arthrocare Corporation | System for electrosurgical treatment of submucosal tissue |
| 6464695, | Jun 07 1995 | Arthrocare Corporation | Method for electrosurgical treatment of intervertebral discs |
| 6468270, | Jun 07 1995 | ArthoCare Corporation | System and method for electrosurgical treatment of intervertebral discs |
| 6468274, | Jul 16 1996 | Arthrocare Corporation | Systems and methods for treating spinal pain |
| 6468275, | Feb 06 1998 | Ethicon Endo-Surgery, Inc. | RF bipolar mesentery takedown device including improved bipolar end effector |
| 6482201, | Jun 07 1995 | Arthrocare Corporation | Systems and methods for tissue resection, ablation and aspiration |
| 6497704, | Apr 04 2001 | Electrosurgical apparatus | |
| 6500173, | Jul 18 1996 | Arthrocare Corporation | Methods for electrosurgical spine surgery |
| 6517498, | Mar 03 1998 | Senorx, Inc | Apparatus and method for tissue capture |
| 6530922, | Dec 15 1993 | Covidien AG; TYCO HEALTHCARE GROUP AG | Cluster ablation electrode system |
| 6540741, | Jul 18 1996 | Arthrocare Corporation | Systems and methods for electrosurgical spine surgery |
| 6558390, | Feb 16 2000 | MIS IP HOLDINGS LLC | Methods and apparatus for performing therapeutic procedures in the spine |
| 6562033, | Apr 09 2001 | CITIBANK, N A | Intradiscal lesioning apparatus |
| 6575968, | Jan 07 1992 | Arthrocare Corp. | Electrosurgical system for treating the spine |
| 6578579, | Sep 07 1999 | Boston Scientific Scimed, Inc | Systems and methods for preventing automatic identification of re-used single use devices |
| 6589237, | May 10 1993 | Arthrocare Corp. | Electrosurgical apparatus and methods for treating tissue |
| 6602248, | Jun 07 1995 | Arthro Care Corp. | Methods for repairing damaged intervertebral discs |
| 6604003, | Sep 07 2000 | TYCO HEALTHCARE GROUP AG; Covidien AG | Apparatus and method for treatment of an intervertebral disc |
| 6620155, | Jul 18 1996 | Arthrocare Corp.; Arthrocare Corporation | System and methods for electrosurgical tissue contraction within the spine |
| 6620156, | Sep 20 2002 | Ellman International, Inc | Bipolar tonsillar probe |
| 6622731, | Jan 11 2001 | AngioDynamics, Inc | Bone-treatment instrument and method |
| 6632193, | Nov 22 1995 | Arthrocare Corporation | Systems and methods for electrosurgical tissue treatment |
| 6632220, | Jan 07 1992 | Arthrocare Corp. | Systems for electrosurgical tissue treatment in conductive fluid |
| 6635087, | Aug 29 2001 | Synthes USA, LLC | Laminoplasty implants and methods of use |
| 6645247, | Oct 08 1999 | ANOVA CORP | Supplementing engineered annulus tissues with autograft of allograft tendons |
| 6679886, | Sep 01 2000 | Synthes USA, LLC | Tools and methods for creating cavities in bone |
| 6712811, | Oct 04 1991 | Arthrocare Corporation | Methods for electrosurgical spine surgery |
| 6726684, | Jul 16 1996 | Arthrocare Corporation | Methods for electrosurgical spine surgery |
| 6740093, | Feb 28 2000 | SPINE WAVE, INC | Method and apparatus for treating a vertebral body |
| 6746451, | Jun 01 2001 | Cavitech, LLC | Tissue cavitation device and method |
| 6749604, | May 10 1993 | Arthrocare Corporation | Electrosurgical instrument with axially-spaced electrodes |
| 6749608, | Aug 05 2002 | Cynosure, Inc | Adenoid curette electrosurgical probe |
| 6758846, | Feb 08 2000 | Gyrus Medical Limited | Electrosurgical instrument and an electrosurgery system including such an instrument |
| 6761718, | Sep 06 2001 | Children's Medical Center Corp. | Direction-oriented and spatially controlled bipolar coagulator for in-situ cauterization of adherent cranial tissue occluding a ventricular catheter previously implanted in-vivo |
| 6770071, | Jun 07 1995 | Arthrocare Corporation | Bladed electrosurgical probe |
| 6772012, | Jun 07 1995 | Arthrocare Corporation | Methods for electrosurgical treatment of spinal tissue |
| 6780178, | May 03 2002 | The Board of Trustees of the Leland Stanford Junior University | Method and apparatus for plasma-mediated thermo-electrical ablation |
| 6780180, | Jun 23 1995 | Gyrus Medical Limited | Electrosurgical instrument |
| 6802842, | Nov 03 2000 | Cynosure, Inc | Electrosurgical tonsilar and adenoid electrode |
| 6827716, | Sep 30 2002 | Depuy Spine, Inc. | Method of identifying and treating a pathologic region of an intervertebral disc |
| 6837884, | Jun 18 2001 | Arthrocare Corporation | Electrosurgical apparatus having compound return electrode |
| 6837887, | Jun 07 1995 | Arthrocare Corporation | Articulated electrosurgical probe and methods |
| 6837888, | Feb 09 2001 | Arthrocare Corporation | Electrosurgical probe with movable return electrode and methods related thereto |
| 6878155, | Feb 25 2000 | NEUROTHERM, INC | Method of treating intervertebral disc tissue employing attachment mechanism |
| 6920883, | Nov 08 2001 | Arthrocare Corporation; ArthoCare Corporation | Methods and apparatus for skin treatment |
| 6929640, | Jul 16 1996 | Arthrocare Corporation | Methods for electrosurgical tissue contraction within the spine |
| 6949096, | Jan 21 1998 | Arthrocare Corporation | Electrosurgical ablation and aspiration apparatus having flow directing feature and methods related thereto |
| 6960204, | May 10 1993 | Arthrocare Corporation | Electrosurgical method using laterally arranged active electrode |
| 6974453, | May 10 1993 | Arthrocare Corporation | Dual mode electrosurgical clamping probe and related methods |
| 6974480, | May 03 2001 | Depuy Synthes Products, LLC | Intervertebral implant for transforaminal posterior lumbar interbody fusion procedure |
| 6991631, | Jun 09 2000 | Arthrocare Corporation | Electrosurgical probe having circular electrode array for ablating joint tissue and systems related thereto |
| 6997885, | Jul 27 2001 | Senorx, Inc | Dilation devices and methods for removing tissue specimens |
| 6997925, | Jul 08 1997 | Atrionx, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
| 7001431, | May 06 1994 | DISC DYNAMICS, INC | Intervertebral disc prosthesis |
| 7004941, | Nov 08 2001 | Arthrocare Corporation | Systems and methods for electrosurigical treatment of obstructive sleep disorders |
| 7014633, | Feb 16 2000 | FORDHAM CAPITAL PARTNERS, LLC | Methods of performing procedures in the spine |
| 7041102, | Oct 22 2001 | Ethicon Endo-Surgery, Inc | Electrosurgical working end with replaceable cartridges |
| 7070596, | Aug 09 2000 | Arthrocare Corporation | Electrosurgical apparatus having a curved distal section |
| 7090672, | Jun 07 1995 | Arthrocare Corporation | Method for treating obstructive sleep disorder includes removing tissue from the base of tongue |
| 7094215, | Oct 02 1997 | Arthrocare Corporation | Systems and methods for electrosurgical tissue contraction |
| 7104986, | Jul 16 1996 | Arthrocare Corporation | Intervertebral disc replacement method |
| 7108696, | Jan 11 2001 | AngioDynamics, Inc | Bone-treatment instrument and method |
| 7131969, | Jun 07 1995 | Arthrocare Corp | Systems and methods for electrosurgical treatment of obstructive sleep disorders |
| 7169143, | May 10 1993 | Arthrocare Corporation | Methods for electrosurgical tissue treatment in electrically conductive fluid |
| 7179255, | Jun 07 1995 | Arthrocare Corporation | Methods for targeted electrosurgery on contained herniated discs |
| 7186234, | Nov 22 1995 | Arthrocare Corporation | Electrosurgical apparatus and methods for treatment and removal of tissue |
| 7192428, | Jun 07 1995 | Arthrocare Corporation | Systems for epidermal tissue ablation |
| 7201750, | Jan 07 1992 | Arthrocare Corporation | System for treating articular cartilage defects |
| 7217268, | Jun 02 1995 | Arthrocare Corporation | Method for electrosurgical tissue treatment near a patient's heart |
| 20020029036, | |||
| 20020049438, | |||
| 20020082698, | |||
| 20020095151, | |||
| 20020120337, | |||
| 20030013986, | |||
| 20030028189, | |||
| 20030088245, | |||
| 20030130738, | |||
| 20030158455, | |||
| 20030171743, | |||
| 20030208194, | |||
| 20030208196, | |||
| 20030212395, | |||
| 20030212396, | |||
| 20040024399, | |||
| 20040049180, | |||
| 20040054366, | |||
| 20040116922, | |||
| 20040127893, | |||
| 20040153057, | |||
| 20040186469, | |||
| 20040230190, | |||
| 20050004634, | |||
| 20050010205, | |||
| 20050119650, | |||
| 20050131402, | |||
| 20050187543, | |||
| 20050234439, | |||
| 20050251134, | |||
| 20050261754, | |||
| 20050288665, | |||
| 20060036237, | |||
| 20060095026, | |||
| 20060095031, | |||
| 20060129145, | |||
| 20060178670, | |||
| 20060189971, | |||
| 20060253117, | |||
| 20060259025, | |||
| 20070001088, | |||
| 20070010809, | |||
| DE3930451, | |||
| EP694290, | |||
| EP703461, | |||
| EP740926, | |||
| EP754437, | |||
| EP5150867, | |||
| EP719162, | |||
| EP774926, | |||
| FR2313949, | |||
| GB2308979, | |||
| GB2308980, | |||
| GB2308981, | |||
| GB2327350, | |||
| GB2327351, | |||
| GB2327352, | |||
| JP57117843, | |||
| JP5757802, | |||
| NL5000434, | |||
| RE33925, | Dec 08 1988 | CORDIS WEBSTER, INC | Electrosurgical catheter aned method for vascular applications |
| WO71043, | |||
| WO7507, | |||
| WO10475, | |||
| WO67698, | |||
| WO126570, | |||
| WO182813, | |||
| WO187154, | |||
| WO211635, | |||
| WO236028, | |||
| WO3024506, | |||
| WO422155, | |||
| WO5122938, | |||
| WO5125287, | |||
| WO539390, | |||
| WO9003152, | |||
| WO9221278, | |||
| WO9320747, | |||
| WO9408524, | |||
| WO9408654, | |||
| WO9414383, | |||
| WO9426228, | |||
| WO9500042, | |||
| WO9505781, | |||
| WO9505867, | |||
| WO9620652, | |||
| WO9623449, | |||
| WO9641574, | |||
| WO9700070, | |||
| WO9700646, | |||
| WO9700647, | |||
| WO9724073, | |||
| WO9724992, | |||
| WO9724993, | |||
| WO9724994, | |||
| WO9748345, | |||
| WO9748346, | |||
| WO9800070, | |||
| WO9801087, | |||
| WO9803220, | |||
| WO9807468, | |||
| WO9811944, | |||
| WO9814131, | |||
| WO9817190, | |||
| WO9827879, | |||
| WO9827880, | |||
| WO9903414, | |||
| WO9942037, | |||
| WO9947058, | |||
| WO9951155, | |||
| WO9951158, | |||
| WO313816, | |||
| WO9007303, | |||
| WO9404220, | |||
| WO9534259, | |||
| WO9724074, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Sep 19 2000 | SHARPS, LEWIS | Arthrocare Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020195 | /0050 | |
| Sep 19 2000 | HOVDA, DAVID C | Arthrocare Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020195 | /0050 | |
| Sep 20 2000 | WOLOSZKO, JEAN | Arthrocare Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020195 | /0050 | |
| Sep 20 2000 | THAPLIYAL, HIRA V | Arthrocare Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020195 | /0050 | |
| Sep 26 2000 | EGGERS, PHILIP E | Arthrocare Corporation | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 020195 | /0050 | |
| Oct 09 2003 | Arthrocare Corporation | (assignment on the face of the patent) | / | |||
| Jan 13 2006 | BANK OF AMERICA, N A | Arthrocare Corporation | RELEASE OF PATENT SECURITY AGREEMENT RECORDED AT REEL 017105 FRAME 0855 | 023180 | /0892 | |
| Jan 13 2006 | Arthrocare Corporation | BANK OF AMERICA, N A | PATENT SECURITY AGREEMENT | 017105 | /0855 |
| Date | Maintenance Fee Events |
| Feb 07 2011 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
| Mar 13 2015 | REM: Maintenance Fee Reminder Mailed. |
| Aug 05 2015 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
| Date | Maintenance Schedule |
| Mar 18 2011 | 4 years fee payment window open |
| Sep 18 2011 | 6 months grace period start (w surcharge) |
| Mar 18 2012 | patent expiry (for year 4) |
| Mar 18 2014 | 2 years to revive unintentionally abandoned end. (for year 4) |
| Mar 18 2015 | 8 years fee payment window open |
| Sep 18 2015 | 6 months grace period start (w surcharge) |
| Mar 18 2016 | patent expiry (for year 8) |
| Mar 18 2018 | 2 years to revive unintentionally abandoned end. (for year 8) |
| Mar 18 2019 | 12 years fee payment window open |
| Sep 18 2019 | 6 months grace period start (w surcharge) |
| Mar 18 2020 | patent expiry (for year 12) |
| Mar 18 2022 | 2 years to revive unintentionally abandoned end. (for year 12) |